US20120203316A1 - Leads with segmented electrodes for electrical stimulation of planar regions and methods of making and using - Google Patents
Leads with segmented electrodes for electrical stimulation of planar regions and methods of making and using Download PDFInfo
- Publication number
- US20120203316A1 US20120203316A1 US13/368,733 US201213368733A US2012203316A1 US 20120203316 A1 US20120203316 A1 US 20120203316A1 US 201213368733 A US201213368733 A US 201213368733A US 2012203316 A1 US2012203316 A1 US 2012203316A1
- Authority
- US
- United States
- Prior art keywords
- lead
- electrodes
- disposed
- stimulation
- segmented electrodes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0526—Head electrodes
- A61N1/0529—Electrodes for brain stimulation
- A61N1/0534—Electrodes for deep brain stimulation
Definitions
- the invention is directed to the area of electrical stimulation systems and methods of making and using the systems.
- the present invention is also directed to electrical stimulation leads with segmented electrodes that can be used for electrical stimulation of planar regions, as well as methods of making and using the segmented electrodes, leads, and electrical stimulation systems.
- Deep brain stimulation can be useful for treating a variety of conditions. Deep brain stimulation can be useful for treating, for example, Parkinson's disease, dystonia, essential tremor, chronic pain, Huntington's Disease, levodopa-induced dyskinesias and rigidity, bradykinesia, epilepsy and seizures, eating disorders, and mood disorders.
- a lead with a stimulating electrode at or near a tip of the lead provides the stimulation to target neurons in the brain.
- Magnetic resonance imaging (“MRI”) or computerized tomography (“CT”) scans can provide a starting point for determining where the stimulating electrode should be positioned to provide the desired stimulus to the target neurons.
- MRI Magnetic resonance imaging
- CT computerized tomography
- electrical stimulus current can be delivered through selected electrodes on the lead to stimulate target neurons in the brain.
- the electrodes are formed into rings disposed on a distal portion of the lead.
- the stimulus current projects from the ring electrodes equally in every direction. Because of the ring shape of these electrodes, the stimulus current cannot be directed to one or more specific positions around the ring electrode (e.g., on one or more sides, or points, around the lead). Consequently, undirected stimulation may result in unwanted stimulation of neighboring neural tissue, potentially resulting in undesired side effects.
- One embodiment is a stimulation lead that includes a lead body having a longitudinal surface, a distal end, and a proximal end; and multiple electrodes disposed along the longitudinal surface of the lead body near the distal end of the lead body.
- the electrodes include multiple groups of segmented electrodes with each group of segmented electrodes having multiple segmented electrodes disposed at a same longitudinal position along the lead. For at least one first group of segmented electrodes, a first pair of the segmented electrodes in the first group are disposed on opposite sides of the lead body and are electrically ganged together by a conductor therebetween.
- kits for implanting a stimulation lead into a patient includes a stimulation lead having a longitudinal surface, a distal end, and at least one electrode disposed along the longitudinal surface of the stimulation lead near the distal end of the stimulation lead. A portion of the stimulation lead upon which the electrode(s) are disposed has a non-circular cross-sectional shape.
- the kit also includes at least one microelectrode lead having a distal end and at least one microelectrode disposed at the distal end of the microelectrode lead.
- the kit further includes an introducer defining a lumen configured and arranged to receive the stimulation lead.
- the introducer has at least one interior wall extending into the lumen and defining at least one microelectrode lumen that is configured and arranged to receive, and hold within the microelectrode lumen, one of the at least one microelectrode leads.
- a further embodiment is a method for stimulating tissue that includes implanting a lead comprising a longitudinal surface, a distal end, a proximal end, two main portions disposed at the distal end of the lead, a bendable portion disposed between the two main portions, multiple electrodes disposed on surfaces of the two main portions of the lead, and multiple terminals disposed along the proximal end of the lead and electrically coupled to the electrodes.
- the bendable portion is bent so that the two main portions are disposed opposite each other and each electrode has an exposed surface through which electrical energy can be supplied to stimulate adjacent tissue when the stimulation lead is implanted.
- the method further includes retaining the lead in the patient with the bendable portion bent; and stimulating adjacent tissue using at least one of the electrodes.
- FIG. 1 is a schematic side view of one embodiment of a device for brain stimulation, according to the invention.
- FIG. 2 is a schematic diagram of radial current steering along various electrode levels along the length of a lead, according to the invention
- FIG. 3A is a perspective view of an embodiment of a portion of a lead having a plurality of segmented electrodes with selected electrodes electrically ganged, according to the invention
- FIG. 3B is a perspective view of a second embodiment of a portion of a lead having a plurality of segmented electrodes with selected electrodes electrically ganged, according to the invention
- FIG. 3C is a perspective view of a third embodiment of a portion of a lead having a plurality of segmented electrodes with selected electrodes electrically ganged, according to the invention.
- FIG. 3D is a perspective view of a fourth embodiment of a portion of a lead having a plurality of segmented electrodes with selected electrodes electrically ganged, according to the invention.
- FIG. 4A is a schematic cross-sectional view of one embodiment of a lead with a non-circular cross-sectional shape that can be implanted using a percutaneous introducer, according to the invention
- FIG. 4B is a schematic top plan view of a portion of one embodiment of the lead of FIG. 4A with an example of an electrode arrangement, according to the invention
- FIG. 5 is a schematic cross-sectional view of one embodiment of a lead disposed in an introducer that also contains microelectrode lumens for receiving microelectrode leads, according to the invention
- FIG. 6A is a schematic cross-sectional view of one embodiment of a lead having two main portions, each containing electrodes, separated by a bendable portion, according to the invention.
- FIG. 6B is a schematic cross-sectional view of one embodiment of the lead of FIG. 6A with the bendable portion bent and the lead disposed in a percutaneous introducer, according to the invention.
- the invention is directed to the area of electrical stimulation systems and methods of making and using the systems.
- the present invention is also directed to electrical stimulation leads with segmented electrodes that can be used for electrical stimulation of planar regions, as well as methods of making and using the segmented electrodes, leads, and electrical stimulation systems.
- a lead for deep brain stimulation may include stimulation electrodes, recording electrodes, or a combination of both. At least some of the stimulation electrodes, recording electrodes, or both are provided in the form of segmented electrodes that extend only partially around the circumference of the lead. These segmented electrodes can be provided in sets of electrodes, with each set having electrodes radially distributed about the lead at a particular longitudinal position.
- a practitioner may determine the position of the target neurons using the recording electrode(s) and then position the stimulation electrode(s) accordingly without removal of a recording lead and insertion of a stimulation lead.
- the same electrodes can be used for both recording and stimulation.
- separate leads can be used; one with recording electrodes which identify target neurons, and a second lead with stimulation electrodes that replaces the first after target neuron identification.
- a lead may include recording electrodes spaced around the circumference of the lead to more precisely determine the position of the target neurons.
- the lead is rotatable so that the stimulation electrodes can be aligned with the target neurons after the neurons have been located using the recording electrodes.
- the leads are described herein relative to use for deep brain stimulation, but it will be understood that any of the leads can be used for applications other than deep brain stimulation, including spinal cord stimulation and stimulation of other nerves and tissues.
- Deep brain stimulation devices and leads are described in, for example, U.S. Pat. No. 7,809,446 (“Devices and Methods For Brain Stimulation”), U.S. Patent Application Publication No. 2010/0076535 A1 (“Leads With Non-Circular-Shaped Distal Ends For Brain Stimulation Systems and Methods of Making and Using”), U.S. Patent Application Publication 2007/0150036 A1 (“Stimulator Leads and Methods For Lead Fabrication”), U.S. patent application Ser. No. 12/177,823 (“Lead With Transition and Methods of Manufacture and Use”), U.S. Patent Application Publication No.
- FIG. 1 illustrates one embodiment of a device 100 for brain stimulation.
- the device includes a lead 110 , a plurality of electrodes 125 disposed at least partially about a circumference of the lead 110 , a plurality of terminals 135 , a connector 130 for connection of the electrodes to a control unit, and a stylet 140 for assisting in insertion and positioning of the lead in the patient's brain.
- the stylet 140 can be made of a rigid material. Examples of suitable materials for the stylet include, but are not limited to, tungsten, stainless steel, and plastic.
- the stylet 140 may have a handle 150 to assist insertion into the lead 110 , as well as rotation of the stylet 140 and lead 110 .
- the connector 130 fits over a proximal end of the lead 110 , preferably after removal of the stylet 140 .
- the control unit (not shown) is typically an implantable pulse generator that can be implanted into a patient's body, for example, below the patient's clavicle area.
- the pulse generator can have eight stimulation channels which may be independently programmable to control the magnitude of the current stimulus from each channel. In some cases the pulse generator may have more or fewer than eight stimulation channels (e.g., 4-, 6-, 16-, 32-, or more stimulation channels).
- the control unit may have one, two, three, four, or more connector ports, for receiving the plurality of terminals 135 at the proximal end of the lead 110 .
- access to the desired position in the brain can be accomplished by drilling a hole in the patient's skull or cranium with a cranial drill (commonly referred to as a burr), and coagulating and incising the dura mater, or brain covering.
- the lead 110 can be inserted into the cranium and brain tissue with the assistance of the stylet 140 .
- the lead 110 can be guided to the target location within the brain using, for example, a stereotactic frame and a microdrive motor system.
- the microdrive motor system can be fully or partially automatic.
- the microdrive motor system may be configured to perform one or more the following actions (alone or in combination): insert the lead 110 , retract the lead 110 , or rotate the lead 110 .
- measurement devices coupled to the muscles or other tissues stimulated by the target neurons, or a unit responsive to the patient or clinician can be coupled to the control unit or microdrive motor system.
- the measurement device, user, or clinician can indicate a response by the target muscles or other tissues to the stimulation or recording electrode(s) to further identify the target neurons and facilitate positioning of the stimulation electrode(s).
- a measurement device can be used to observe the muscle and indicate changes in tremor frequency or amplitude in response to stimulation of neurons.
- the patient or clinician may observe the muscle and provide feedback.
- the lead 110 for deep brain stimulation can include stimulation electrodes, recording electrodes, or both.
- the lead 110 is rotatable so that the stimulation electrodes can be aligned with the target neurons after the neurons have been located using the recording electrodes.
- Stimulation electrodes may be disposed on the circumference of the lead 110 to stimulate the target neurons. Stimulation electrodes may be ring-shaped so that current projects from each electrode equally in every direction from the position of the electrode along a length of the lead 110 . Ring electrodes, however, typically do not enable stimulus current to be directed to only one side of the lead. Segmented electrodes, however, can be used to direct stimulus current to one side, or even a portion of one side, of the lead. When segmented electrodes are used in conjunction with an implantable pulse generator that delivers constant current stimulus, current steering can be achieved to more precisely deliver the stimulus to a position around an axis of the lead (i.e., radial positioning around the axis of the lead).
- segmented electrodes can be utilized in addition to, or as an alternative to, ring electrodes. Though the following description discusses stimulation electrodes, it will be understood that all configurations of the stimulation electrodes discussed may be utilized in arranging recording electrodes as well.
- the lead 100 includes a lead body 110 , one or more optional ring electrodes 120 , and a plurality of sets of segmented electrodes 130 .
- the lead body 110 can be formed of a biocompatible, non-conducting material such as, for example, a polymeric material. Suitable polymeric materials include, but are not limited to, silicone, polyurethane, polyurea, polyurethane-urea, polyethylene, or the like.
- the lead 100 may be in contact with body tissue for extended periods of time.
- the lead 100 has a cross-sectional diameter of no more than 1.5 mm and may be in the range of 1 to 1.5 mm.
- the lead 100 has a length of at least 10 cm and the length of the lead 100 may be in the range of 25 to 70 cm.
- the electrodes may be made using a metal, alloy, conductive oxide, or any other suitable conductive biocompatible material.
- suitable materials include, but are not limited to, platinum, platinum iridium alloy, iridium, titanium, tungsten, palladium, palladium rhodium, or the like.
- the electrodes are made of a material that is biocompatible and does not substantially corrode under expected operating conditions in the operating environment for the expected duration of use.
- Each of the electrodes can either be used or unused (OFF).
- the electrode can be used as an anode or cathode and carry anodic or cathodic current.
- an electrode might be an anode for a period of time and a cathode for a period of time.
- Stimulation electrodes in the form of ring electrodes 120 may be disposed on any part of the lead body 110 , usually near a distal end of the lead 100 .
- the lead 100 includes two ring electrodes 120 .
- Any number of ring electrodes 120 may be disposed along the length of the lead body 110 including, for example, one, two three, four, five, six, seven, eight, nine, ten, eleven, twelve, thirteen, fourteen, fifteen, sixteen or more ring electrodes 120 . It will be understood that any number of ring electrodes may be disposed along the length of the lead body 110 .
- the ring electrodes 120 are substantially cylindrical and wrap around the entire circumference of the lead body 110 .
- the outer diameters of the ring electrodes 120 are substantially equal to the outer diameter of the lead body 110 .
- the length of the ring electrodes 120 may vary according to the desired treatment and the location of the target neurons. In some embodiments the length of the ring electrodes 120 are less than or equal to the diameters of the ring electrodes 120 . In other embodiments, the lengths of the ring electrodes 120 are greater than the diameters of the ring electrodes 120 .
- Deep brain stimulation leads may include one or more sets of segmented electrodes. Segmented electrodes may provide for superior current steering than ring electrodes because target structures in deep brain stimulation are not typically symmetric about the axis of the distal electrode array. Instead, a target may be located on one side of a plane running through the axis of the lead.
- RSEA radially segmented electrode array
- the lead 100 is shown having a plurality of segmented electrodes 130 .
- Any number of segmented electrodes 130 may be disposed on the lead body 110 including, for example, one, two three, four, five, six, seven, eight, nine, ten, eleven, twelve, thirteen, fourteen, fifteen, sixteen or more segmented electrodes 130 . It will be understood that any number of segmented electrodes 130 may be disposed along the length of the lead body 110 .
- the segmented electrodes 130 may be grouped into sets of segmented electrodes, where each set is disposed around a circumference of the lead 100 at a particular longitudinal portion of the lead 100 .
- the lead 100 may have any number segmented electrodes 130 in a given set of segmented electrodes.
- the lead 100 may have one, two, three, four, five, six, seven, eight, or more segmented electrodes 130 in a given set.
- each set of segmented electrodes 130 of the lead 100 contains the same number of segmented electrodes 130 .
- the segmented electrodes 130 disposed on the lead 100 may include a different number of electrodes than at least one other set of segmented electrodes 130 disposed on the lead 100 .
- the segmented electrodes 130 may vary in size and shape. In some embodiments, the segmented electrodes 130 are all of the same size, shape, diameter, width or area or any combination thereof. In some embodiments, the segmented electrodes 130 of each circumferential set (or even all segmented electrodes disposed on the lead 100 ) may be identical in size and shape.
- Each set of segmented electrodes 130 may be disposed around the circumference of the lead body 110 to form a substantially cylindrical shape around the lead body 110 .
- the spacing between individual electrodes of a given set of the segmented electrodes may be the same, or different from, the spacing between individual electrodes of another set of segmented electrodes on the lead 100 .
- equal spaces, gaps or cutouts are disposed between each segmented electrode 130 around the circumference of the lead body 110 .
- the spaces, gaps or cutouts between the segmented electrodes 130 may differ in size or shape.
- the spaces, gaps, or cutouts between segmented electrodes 130 may be uniform for a particular set of the segmented electrodes 130 , or for all sets of the segmented electrodes 130 .
- the sets of segmented electrodes 130 may be positioned in irregular or regular intervals along a length the lead body 110 .
- Conductor wires that attach to the ring electrodes 120 or segmented electrodes 130 extend along the lead body 110 . These conductor wires may extend through the material of the lead 100 or along one or more lumens defined by the lead 100 , or both. The conductor wires are presented at a connector (via terminals) for coupling of the electrodes 120 , 130 to a control unit (not shown).
- the ring electrodes 120 and the segmented electrodes 130 may be arranged in any suitable configuration.
- the ring electrodes 120 can flank the two sets of segmented electrodes 130 (see e.g., FIG. 1 ).
- the two sets of ring electrodes 120 can be disposed proximal to the two sets of segmented electrodes 130 (see e.g., FIG. 3C ), or the two sets of ring electrodes 120 can be disposed distal to the two sets of segmented electrodes 130 (see e.g., FIG. 3D ).
- FIG. 3D alternating ring and segmented electrodes, or the like.
- the electrode arrangement of FIG. 3C may be useful if the physician anticipates that the neural target will be closer to a distal tip of the lead body 110
- the electrode arrangement of FIG. 3D may be useful if the physician anticipates that the neural target will be closer to a proximal end of the lead body 110 .
- any combination of ring electrodes 120 and segmented electrodes 130 may be disposed on the lead 100 .
- the lead may include a first ring electrode 120 , two sets of segmented electrodes; each set formed of four segmented electrodes 130 , and a final ring electrode 120 at the end of the lead.
- This configuration may simply be referred to as a 1-4-4-1 configuration. It may be useful to refer to the electrodes with this shorthand notation.
- the embodiment of FIG. 3C may be referred to as a 1-1-4-4 configuration
- the embodiment of FIG. 3D may be referred to as a 4-4-1-1 configuration.
- Electrodes configurations include, for example, a 2-2-2-2 configuration, where four sets of segmented electrodes are disposed on the lead, and a 4-4 configuration, where two sets of segmented electrodes, each having four segmented electrodes 130 are disposed on the lead.
- the lead includes 16 electrodes. Possible configurations for a 16-electrode lead include, but are not limited to 4-4-4-4; 8-8; 3-3-3-3-3-1 (and all rearrangements of this configuration); and 2-2-2-2-2-2-2-2-2-2.
- FIG. 2 is a schematic diagram to illustrate radial current steering along various electrode levels along the length of the lead 200 .
- the segmented electrode configuration is capable of steering current in the x-axis, y-axis as well as the z-axis.
- the centroid of stimulation may be steered in any direction in the three-dimensional space surrounding the lead 200 .
- the radial distance, r, and the angle ⁇ around the circumference of the lead 200 may be dictated by the percentage of anodic current (recognizing that stimulation predominantly occurs near the cathode, although strong anodes may cause stimulation as well) introduced to each electrode.
- the configuration of anodes and cathodes along the segmented electrodes allows the centroid of stimulation to be shifted to a variety of different locations along the lead 200 .
- the centroid of stimulation can be shifted at each level along the length of the lead 200 .
- the use of multiple sets of segmented electrodes at different levels along the length of the lead allows for three-dimensional current steering.
- the sets of segmented electrodes are shifted collectively (i.e., the centroid of simulation is similar at each level along the length of the lead).
- each set of segmented electrodes is controlled independently.
- Each set of segmented electrodes may contain two, three, four, five, six, seven, eight or more segmented electrodes. It will be understood that different stimulation profiles may be produced by varying the number of segmented electrodes at each level.
- each set of segmented electrodes includes only two segmented electrodes, uniformly distributed gaps (inability to stimulate selectively) may be formed in the stimulation profile.
- at least three segmented electrodes 230 in a set are utilized to allow for true 360° selectivity.
- measurement devices coupled to the muscles or other tissues stimulated by the target neurons or a unit responsive to the patient or clinician can be coupled to the control unit or microdrive motor system.
- the measurement device, user, or clinician can indicate a response by the target muscles or other tissues to the stimulation or recording electrodes to further identify the target neurons and facilitate positioning of the stimulation electrodes.
- a measurement device can be used to observe the muscle and indicate changes in tremor frequency or amplitude in response to stimulation of neurons.
- the patient or clinician may observe the muscle and provide feedback.
- the lead 100 when the lead 100 includes a plurality of sets of segmented electrodes 130 , it may be desirable to form the lead 100 such that corresponding electrodes of different sets of segmented electrodes 130 are radially aligned with one another along the length of the lead 100 (see e.g., the segmented electrodes 130 shown in FIG. 1 ). Radial alignment between corresponding electrodes of different sets of segmented electrodes 130 along the length of the lead 100 may reduce uncertainty as to the location or orientation between corresponding segmented electrodes of different sets of segmented electrodes.
- electrode arrays such that corresponding electrodes of different sets of segmented electrodes along the length of the lead 100 are radially aligned with one another and do not radially shift in relation to one another during manufacturing of the lead 100 .
- individual electrodes in the two sets of segmented electrodes 130 are staggered relative to one another along the length of the lead body 110 .
- the staggered positioning of corresponding electrodes of different sets of segmented electrodes along the length of the lead 100 may be designed for a specific application.
- Segmented electrodes can be used to tailor the stimulation region so that, instead of stimulating tissue around the circumference of the lead as would be achieved using a ring electrode, the stimulation region can be directionally targeted. In some instances, it is desirable to target a parallelepiped (or slab) region 250 that contains the electrodes of the lead 200 , as illustrated in FIG. 2 .
- One arrangement for directing a stimulation field into a parallelepiped region uses segmented electrodes disposed on opposite sides of a lead.
- FIGS. 3A-3D illustrate leads 300 with segmented electrodes 330 , optional ring electrodes 320 , and a lead body 310 .
- the groups of segmented electrodes 330 include either two ( FIG. 3B ) or four ( FIGS. 3A , 3 C, and 3 D) segmented electrodes. It will be recognized that other groups of segmented electrodes with an even number of electrodes in the group can also be used.
- segmented electrodes on opposite sides of the lead are ganged (i.e., electrically coupled) together, as illustrated schematically by the lines 360 .
- One arrangement for ganging two segmented electrodes together which includes coupling the two electrodes (for example, electrodes 330 a and 330 b ) using a conductor (represented by line 360 ) that passes through the lead body.
- This conductor can be coupled to another conductor (not shown) that passes through the lead body to the proximal end of the lead to provide for connection to a terminal or contact at the proximal end of the lead.
- one electrode for example, electrode 330 a
- a conductor (not shown) that passes through the lead body to the proximal end of the lead to provide for connection to a terminal or contact at the proximal end of the lead and the other electrode (for example, electrode 330 b ) is coupled to the first electrode by the conductor represented by line 360 .
- This conductor might be a wire or may be a thin, flat conductor.
- stimulation current is applied through the ganged segmented electrodes (for example, electrodes 330 a and 330 b ).
- the ganged segmented electrodes can operate as cathodes.
- other ganged electrodes for example, electrodes 330 c and 330 d
- may be assigned the opposite polarity for example, as anodes which may further direct the stimulation field into the desired parallelepiped region.
- multiple pairs of ganged segmented electrodes 330 can be provided in each group of segmented electrodes.
- the pairs of ganged segmented electrodes 330 are radially offset from each other. For example, two pairs may be radially offset by an angle in the range of 75 to 115 degrees or by an angle in the range of 80 to 110 degrees or be an angle of 90 degrees.
- the pairs of ganged segmented electrodes can be longitudinally staggered with respect to each other.
- the staggered pairs of ganged segmented electrodes may include electrode portions that are at a same longitudinal position (i.e., the two pairs overlap longitudinally—but not radially). In other embodiments, the electrodes of the staggered pairs do not overlap longitudinally (i.e., no portions of the electrodes of the two pairs have the same longitudinal position on the lead).
- segmented electrodes and pairs of ganged segmented electrodes
- One embodiment includes a double helix with the electrodes at each longitudinal position along the two helices ganged together.
- the segmented electrodes can be coupled to a multiplexer (which is preferably disposed in the lead near the electrodes) or to controllable switches (which are preferably disposed in the lead near the electrodes).
- the multiplexer or controllable switches can be used to electrically gang segmented electrodes together, but can also be used to change which electrodes are ganged together, if desired.
- FIGS. 4A and 4B illustrate portions of a lead 400 with a lead body 410 having a non-circular cross-section and including two elongated surfaces upon which electrodes 430 are disposed.
- This lead 400 is sized so that it can be implanted percutaneously using an introducer 470 such as a percutaneous needle or cannula.
- the lead body 410 can have any suitable non-circular cross-sectional shape including, but not limited to, oval, rectangular, square, or rectangular/square with rounded corners (as illustrated in FIG. 4 ), or the like.
- the non-circular cross-sectional shape of the lead extends the entire length of the lead.
- the non-circular cross-sectional shape of the lead only extends a portion (for example, a portion including the region near the distal end upon which the electrodes are disposed) of the length of the lead with the remainder of the lead having a circular cross-sectional shape (for example, a portion including the proximal end of the lead).
- the lead body 410 has two opposing surfaces upon which electrodes 430 can be disposed. These surfaces may be flat or curved.
- the electrodes are coupled to terminals (not shown) on the proximal end of the lead by conductors (not shown) that extend along the length of the lead.
- the electrodes can be formed using any biocompatible conductive material. Examples of suitable materials include metals, alloys, conductive polymers, conductive carbon, and the like, as well as combinations thereof. In at least some embodiments, one or more of the electrodes are formed from one or more of: platinum, platinum iridium, palladium, titanium nitride, or rhenium.
- the electrodes 430 can be disposed in an array on each of the surfaces of the lead, as illustrated in FIG. 4B .
- the number of electrodes 430 in the array of electrodes on a particular surface of the lead may vary. For example, there can be two, three, four, five, six, seven, eight, nine, ten, eleven, twelve, thirteen, fourteen, fifteen, sixteen, or more electrodes. As will be recognized, other numbers of electrodes may also be used.
- the electrodes 140 can be formed in any suitable shape including, for example, round, oval, triangular, rectangular, pentagonal, hexagonal, heptagonal, octagonal, or the like.
- the electrodes 430 of an array can be arranged in any arrangement including arrangements with in one or more columns, one or more rows, or both rows and columns (as illustrated in FIG. 4B ).
- the electrodes 430 in a row or column may be aligned with an adjacent row or column or may be staggered with respect to an adjacent row or column.
- the arrays on the two opposing sides can be the same or different.
- the electrodes 430 are typically disposed in, or separated by, a non-conductive, biocompatible material of the lead body 410 including, for example, silicone, polyurethane, and the like or combinations thereof.
- the lead body 410 may be formed in the desired shape by any process including, for example, molding (including injection molding), casting, and the like. Electrodes and connecting wires can be disposed onto or within the lead body either prior to or subsequent to a molding or casting process.
- electrodes 430 on opposite sides (and, preferably, directly opposite each other) of the lead body 410 can be ganged together in a manner similar to that illustrated for the embodiments of FIGS. 3A-3D .
- electrodes 430 on the same side of the lead body 410 (for example, electrodes in a row or column) can be ganged together.
- a lead with a lead body having a non-circular cross-sectional shape and electrodes disposed thereon can be formed using an suitable technique including forming a lead body around electrodes disposed in two sides of a mold. In at least some instances, it may be easier or more economical to form electrodes on one side of a lead body.
- FIGS. 6A and 6B illustrate one method for forming a lead body 610 having a non-circular cross-sectional shape and electrodes 630 disposed on opposing sides of the lead body. As illustrated in FIG. 6A , a lead body 610 with electrodes 630 disposed on one side of the lead body is formed.
- the electrodes 630 can be attached to conductors (not shown) which can extend along the lead to terminals or contact on a distal end of the lead. These electrodes 630 can be placed in a mold and then the lead body 610 molded around the electrodes 630 leaving a surface of each electrode exposed.
- the lead body 610 includes two main portions 612 divided by a bendable portion 614 .
- the electrodes are disposed on the two main portions 612 .
- the bendable portion 614 has a thickness that is substantially less than a thickness of the two main portions.
- the bendable portion 612 may include one or more hinges, one or more holes, one or more reduced-thickness portion, or any other suitable structure that facilitates bending or folding of the bendable portion.
- the bendable portion 614 is bent so that the two main portions 612 are disposed opposite each other, as illustrated in FIG. 6B .
- This lead body 610 can be inserted into an introducer 670 .
- the bendable portion 614 contains material that retains the bend once bent.
- the bendable portion 614 is resilient and may spring back to its original shape or some intermediate position.
- one or more fasteners e.g., straps, hooks, and the like
- sutures disposed around the lead body, or adhesive may be provided to retain the lead body 610 in the bent shape.
- the lead body 610 retains the bent shape once implanted due to the presence of adjacent tissue.
- a recording electrode lead When implanting a lead, particularly in the brain, it can be useful to provide a recording electrode that can be used to identify the tissue that is to be stimulated.
- a recording electrode lead is inserted into an introducer and the introducer is inserted into the patient. The introducer is then moved through the tissue using the recording electrode to identify which tissue is to be stimulated. Once the desired tissue is identified, the recording electrode lead is removed from the introducer and a stimulating electrode lead is inserted.
- This conventional procedure can take additional time for removal and insertion of multiple leads.
- the introducer may inadvertently move during removal of the recording electrode lead and the insertion of the stimulating electrode lead which may result in the stimulating electrode lead being no longer aligned with the desired tissue.
- FIG. 5 illustrates one embodiment of such a system with an introducer 570 (e.g., a cannula or a needle) defining an introducer lumen 572 into which a stimulation lead 500 (which can correspond to the lead 400 of FIGS. 4A and 4B ) can be inserted.
- an introducer 570 e.g., a cannula or a needle
- a stimulation lead 500 which can correspond to the lead 400 of FIGS. 4A and 4B
- FIG. 5 illustrates two microelectrode lumens, but in other embodiments only one microelectrode lumen is provided.
- a microelectrode lead 580 can be inserted with each microelectrode lumen 574 formed within the introducer 570 .
- the microelectrode lead 580 includes a microelectrode at a tip of the microelectrode lead 580 which can be used as a recording electrode to identify tissue to be stimulated.
- the microelectrode lead 580 may be, for example, a guidewire or other suitable lead structure.
- the walls 582 which form the microelectrode lumens 574 can be cylindrical or any other suitable shape.
- the walls 582 surround the entire lumen (e.g., have a circular cross-section) or may include openings (for example, have a C-shape in cross-section, as illustrated in FIG. 5 ).
- a portion of the wall of the introducer may form part of the wall 582 of the microelectrode lumens 574 .
- the walls 582 may extend the entire length of the introducer 570 or may only extend partway along the introducer, for example, partway from the distal end or the proximal end or a combination thereof.
- both the microelectrode lead(s) 580 and stimulation lead are inserted into the introducer prior to insertion of the introducer into the patient.
- the microelectrode lead(s) may be inserted into the introducer prior to, or after, insertion of the introducer into the patient and then the microelectrode lead(s) are used to identify the tissue to be stimulated. Later, the stimulation lead may be inserted into the introducer with the microelectrode lead(s) remaining in the introducer. The microelectrode lead(s) can be used to verify that the stimulation lead is properly positioned after it insertion into the introducer in the patient.
Landscapes
- Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Electrotherapy Devices (AREA)
Abstract
One embodiment is a stimulation lead that includes a lead body having a longitudinal surface, a distal end, and a proximal end; and multiple electrodes disposed along the longitudinal surface of the lead body near the distal end of the lead body. The electrodes include multiple groups of segmented electrodes with each group of segmented electrodes having multiple segmented electrodes disposed at a same longitudinal position along the lead. For at least one first group of segmented electrodes, a first pair of the segmented electrodes in the first group are disposed on opposite sides of the lead body and are electrically ganged together by a conductor therebetween.
Description
- This application claims the benefit under 35 U.S.C. §119(e) of U.S. Provisional Patent Application Ser. No. 61/440,546 filed on Feb. 8, 2011, which is incorporated herein by reference.
- The invention is directed to the area of electrical stimulation systems and methods of making and using the systems. The present invention is also directed to electrical stimulation leads with segmented electrodes that can be used for electrical stimulation of planar regions, as well as methods of making and using the segmented electrodes, leads, and electrical stimulation systems.
- Electrical stimulation can be useful for treating a variety of conditions. Deep brain stimulation can be useful for treating, for example, Parkinson's disease, dystonia, essential tremor, chronic pain, Huntington's Disease, levodopa-induced dyskinesias and rigidity, bradykinesia, epilepsy and seizures, eating disorders, and mood disorders. Typically, a lead with a stimulating electrode at or near a tip of the lead provides the stimulation to target neurons in the brain. Magnetic resonance imaging (“MRI”) or computerized tomography (“CT”) scans can provide a starting point for determining where the stimulating electrode should be positioned to provide the desired stimulus to the target neurons.
- After the lead is implanted into a patient's brain, electrical stimulus current can be delivered through selected electrodes on the lead to stimulate target neurons in the brain. Typically, the electrodes are formed into rings disposed on a distal portion of the lead. The stimulus current projects from the ring electrodes equally in every direction. Because of the ring shape of these electrodes, the stimulus current cannot be directed to one or more specific positions around the ring electrode (e.g., on one or more sides, or points, around the lead). Consequently, undirected stimulation may result in unwanted stimulation of neighboring neural tissue, potentially resulting in undesired side effects.
- One embodiment is a stimulation lead that includes a lead body having a longitudinal surface, a distal end, and a proximal end; and multiple electrodes disposed along the longitudinal surface of the lead body near the distal end of the lead body. The electrodes include multiple groups of segmented electrodes with each group of segmented electrodes having multiple segmented electrodes disposed at a same longitudinal position along the lead. For at least one first group of segmented electrodes, a first pair of the segmented electrodes in the first group are disposed on opposite sides of the lead body and are electrically ganged together by a conductor therebetween.
- Another embodiment is a kit for implanting a stimulation lead into a patient. The kit includes a stimulation lead having a longitudinal surface, a distal end, and at least one electrode disposed along the longitudinal surface of the stimulation lead near the distal end of the stimulation lead. A portion of the stimulation lead upon which the electrode(s) are disposed has a non-circular cross-sectional shape. The kit also includes at least one microelectrode lead having a distal end and at least one microelectrode disposed at the distal end of the microelectrode lead. The kit further includes an introducer defining a lumen configured and arranged to receive the stimulation lead. The introducer has at least one interior wall extending into the lumen and defining at least one microelectrode lumen that is configured and arranged to receive, and hold within the microelectrode lumen, one of the at least one microelectrode leads.
- A further embodiment is a method for stimulating tissue that includes implanting a lead comprising a longitudinal surface, a distal end, a proximal end, two main portions disposed at the distal end of the lead, a bendable portion disposed between the two main portions, multiple electrodes disposed on surfaces of the two main portions of the lead, and multiple terminals disposed along the proximal end of the lead and electrically coupled to the electrodes. The bendable portion is bent so that the two main portions are disposed opposite each other and each electrode has an exposed surface through which electrical energy can be supplied to stimulate adjacent tissue when the stimulation lead is implanted. The method further includes retaining the lead in the patient with the bendable portion bent; and stimulating adjacent tissue using at least one of the electrodes.
- Non-limiting and non-exhaustive embodiments of the present invention are described with reference to the following drawings. In the drawings, like reference numerals refer to like parts throughout the various figures unless otherwise specified.
- For a better understanding of the present invention, reference will be made to the following Detailed Description, which is to be read in association with the accompanying drawings, wherein:
-
FIG. 1 is a schematic side view of one embodiment of a device for brain stimulation, according to the invention; -
FIG. 2 is a schematic diagram of radial current steering along various electrode levels along the length of a lead, according to the invention; -
FIG. 3A is a perspective view of an embodiment of a portion of a lead having a plurality of segmented electrodes with selected electrodes electrically ganged, according to the invention; -
FIG. 3B is a perspective view of a second embodiment of a portion of a lead having a plurality of segmented electrodes with selected electrodes electrically ganged, according to the invention; -
FIG. 3C is a perspective view of a third embodiment of a portion of a lead having a plurality of segmented electrodes with selected electrodes electrically ganged, according to the invention; -
FIG. 3D is a perspective view of a fourth embodiment of a portion of a lead having a plurality of segmented electrodes with selected electrodes electrically ganged, according to the invention; -
FIG. 4A is a schematic cross-sectional view of one embodiment of a lead with a non-circular cross-sectional shape that can be implanted using a percutaneous introducer, according to the invention; -
FIG. 4B is a schematic top plan view of a portion of one embodiment of the lead ofFIG. 4A with an example of an electrode arrangement, according to the invention; -
FIG. 5 is a schematic cross-sectional view of one embodiment of a lead disposed in an introducer that also contains microelectrode lumens for receiving microelectrode leads, according to the invention; -
FIG. 6A is a schematic cross-sectional view of one embodiment of a lead having two main portions, each containing electrodes, separated by a bendable portion, according to the invention; and -
FIG. 6B is a schematic cross-sectional view of one embodiment of the lead ofFIG. 6A with the bendable portion bent and the lead disposed in a percutaneous introducer, according to the invention. - The invention is directed to the area of electrical stimulation systems and methods of making and using the systems. The present invention is also directed to electrical stimulation leads with segmented electrodes that can be used for electrical stimulation of planar regions, as well as methods of making and using the segmented electrodes, leads, and electrical stimulation systems.
- A lead for deep brain stimulation may include stimulation electrodes, recording electrodes, or a combination of both. At least some of the stimulation electrodes, recording electrodes, or both are provided in the form of segmented electrodes that extend only partially around the circumference of the lead. These segmented electrodes can be provided in sets of electrodes, with each set having electrodes radially distributed about the lead at a particular longitudinal position.
- A practitioner may determine the position of the target neurons using the recording electrode(s) and then position the stimulation electrode(s) accordingly without removal of a recording lead and insertion of a stimulation lead. In some embodiments, the same electrodes can be used for both recording and stimulation. In some embodiments, separate leads can be used; one with recording electrodes which identify target neurons, and a second lead with stimulation electrodes that replaces the first after target neuron identification. A lead may include recording electrodes spaced around the circumference of the lead to more precisely determine the position of the target neurons. In at least some embodiments, the lead is rotatable so that the stimulation electrodes can be aligned with the target neurons after the neurons have been located using the recording electrodes. For illustrative purposes, the leads are described herein relative to use for deep brain stimulation, but it will be understood that any of the leads can be used for applications other than deep brain stimulation, including spinal cord stimulation and stimulation of other nerves and tissues.
- Deep brain stimulation devices and leads are described in, for example, U.S. Pat. No. 7,809,446 (“Devices and Methods For Brain Stimulation”), U.S. Patent Application Publication No. 2010/0076535 A1 (“Leads With Non-Circular-Shaped Distal Ends For Brain Stimulation Systems and Methods of Making and Using”), U.S. Patent Application Publication 2007/0150036 A1 (“Stimulator Leads and Methods For Lead Fabrication”), U.S. patent application Ser. No. 12/177,823 (“Lead With Transition and Methods of Manufacture and Use”), U.S. Patent Application Publication No. 2009/0276021 A1 (“Electrodes For Stimulation Leads and Methods of Manufacture and Use”), U.S. Patent Application Ser. No. 61/170,037 (“Deep Brain Stimulation Current Steering with Split Electrodes”), U.S. Patent Application Ser. No. 61/022,953, U.S. Patent Application Ser. No. 61/316,759, U.S. Patent Application Publication No. 2009/0187222 A1, and U.S. Patent Application Ser. No. 61/426,784. Each of these references is incorporated herein by reference.
-
FIG. 1 illustrates one embodiment of adevice 100 for brain stimulation. The device includes alead 110, a plurality ofelectrodes 125 disposed at least partially about a circumference of thelead 110, a plurality ofterminals 135, aconnector 130 for connection of the electrodes to a control unit, and astylet 140 for assisting in insertion and positioning of the lead in the patient's brain. Thestylet 140 can be made of a rigid material. Examples of suitable materials for the stylet include, but are not limited to, tungsten, stainless steel, and plastic. Thestylet 140 may have ahandle 150 to assist insertion into thelead 110, as well as rotation of thestylet 140 and lead 110. Theconnector 130 fits over a proximal end of thelead 110, preferably after removal of thestylet 140. - The control unit (not shown) is typically an implantable pulse generator that can be implanted into a patient's body, for example, below the patient's clavicle area. The pulse generator can have eight stimulation channels which may be independently programmable to control the magnitude of the current stimulus from each channel. In some cases the pulse generator may have more or fewer than eight stimulation channels (e.g., 4-, 6-, 16-, 32-, or more stimulation channels). The control unit may have one, two, three, four, or more connector ports, for receiving the plurality of
terminals 135 at the proximal end of thelead 110. - In one example of operation, access to the desired position in the brain can be accomplished by drilling a hole in the patient's skull or cranium with a cranial drill (commonly referred to as a burr), and coagulating and incising the dura mater, or brain covering. The
lead 110 can be inserted into the cranium and brain tissue with the assistance of thestylet 140. Thelead 110 can be guided to the target location within the brain using, for example, a stereotactic frame and a microdrive motor system. In some embodiments, the microdrive motor system can be fully or partially automatic. The microdrive motor system may be configured to perform one or more the following actions (alone or in combination): insert thelead 110, retract thelead 110, or rotate thelead 110. - In some embodiments, measurement devices coupled to the muscles or other tissues stimulated by the target neurons, or a unit responsive to the patient or clinician, can be coupled to the control unit or microdrive motor system. The measurement device, user, or clinician can indicate a response by the target muscles or other tissues to the stimulation or recording electrode(s) to further identify the target neurons and facilitate positioning of the stimulation electrode(s). For example, if the target neurons are directed to a muscle experiencing tremors, a measurement device can be used to observe the muscle and indicate changes in tremor frequency or amplitude in response to stimulation of neurons. Alternatively, the patient or clinician may observe the muscle and provide feedback.
- The
lead 110 for deep brain stimulation can include stimulation electrodes, recording electrodes, or both. In at least some embodiments, thelead 110 is rotatable so that the stimulation electrodes can be aligned with the target neurons after the neurons have been located using the recording electrodes. - Stimulation electrodes may be disposed on the circumference of the
lead 110 to stimulate the target neurons. Stimulation electrodes may be ring-shaped so that current projects from each electrode equally in every direction from the position of the electrode along a length of thelead 110. Ring electrodes, however, typically do not enable stimulus current to be directed to only one side of the lead. Segmented electrodes, however, can be used to direct stimulus current to one side, or even a portion of one side, of the lead. When segmented electrodes are used in conjunction with an implantable pulse generator that delivers constant current stimulus, current steering can be achieved to more precisely deliver the stimulus to a position around an axis of the lead (i.e., radial positioning around the axis of the lead). - To achieve current steering, segmented electrodes can be utilized in addition to, or as an alternative to, ring electrodes. Though the following description discusses stimulation electrodes, it will be understood that all configurations of the stimulation electrodes discussed may be utilized in arranging recording electrodes as well.
- The
lead 100 includes alead body 110, one or moreoptional ring electrodes 120, and a plurality of sets ofsegmented electrodes 130. Thelead body 110 can be formed of a biocompatible, non-conducting material such as, for example, a polymeric material. Suitable polymeric materials include, but are not limited to, silicone, polyurethane, polyurea, polyurethane-urea, polyethylene, or the like. Once implanted in the body, thelead 100 may be in contact with body tissue for extended periods of time. In at least some embodiments, thelead 100 has a cross-sectional diameter of no more than 1.5 mm and may be in the range of 1 to 1.5 mm. In at least some embodiments, thelead 100 has a length of at least 10 cm and the length of thelead 100 may be in the range of 25 to 70 cm. - The electrodes may be made using a metal, alloy, conductive oxide, or any other suitable conductive biocompatible material. Examples of suitable materials include, but are not limited to, platinum, platinum iridium alloy, iridium, titanium, tungsten, palladium, palladium rhodium, or the like. Preferably, the electrodes are made of a material that is biocompatible and does not substantially corrode under expected operating conditions in the operating environment for the expected duration of use.
- Each of the electrodes can either be used or unused (OFF). When the electrode is used, the electrode can be used as an anode or cathode and carry anodic or cathodic current. In some instances, an electrode might be an anode for a period of time and a cathode for a period of time.
- Stimulation electrodes in the form of
ring electrodes 120 may be disposed on any part of thelead body 110, usually near a distal end of thelead 100. InFIG. 1 , thelead 100 includes tworing electrodes 120. Any number ofring electrodes 120 may be disposed along the length of thelead body 110 including, for example, one, two three, four, five, six, seven, eight, nine, ten, eleven, twelve, thirteen, fourteen, fifteen, sixteen ormore ring electrodes 120. It will be understood that any number of ring electrodes may be disposed along the length of thelead body 110. In some embodiments, thering electrodes 120 are substantially cylindrical and wrap around the entire circumference of thelead body 110. In some embodiments, the outer diameters of thering electrodes 120 are substantially equal to the outer diameter of thelead body 110. The length of thering electrodes 120 may vary according to the desired treatment and the location of the target neurons. In some embodiments the length of thering electrodes 120 are less than or equal to the diameters of thering electrodes 120. In other embodiments, the lengths of thering electrodes 120 are greater than the diameters of thering electrodes 120. - Deep brain stimulation leads may include one or more sets of segmented electrodes. Segmented electrodes may provide for superior current steering than ring electrodes because target structures in deep brain stimulation are not typically symmetric about the axis of the distal electrode array. Instead, a target may be located on one side of a plane running through the axis of the lead. Through the use of a radially segmented electrode array (“RSEA”), current steering can be performed not only along a length of the lead but also around a circumference of the lead. This provides precise three-dimensional targeting and delivery of the current stimulus to neural target tissue, while potentially avoiding stimulation of other tissue.
- In
FIG. 1 , thelead 100 is shown having a plurality ofsegmented electrodes 130. Any number ofsegmented electrodes 130 may be disposed on thelead body 110 including, for example, one, two three, four, five, six, seven, eight, nine, ten, eleven, twelve, thirteen, fourteen, fifteen, sixteen or moresegmented electrodes 130. It will be understood that any number ofsegmented electrodes 130 may be disposed along the length of thelead body 110. - The
segmented electrodes 130 may be grouped into sets of segmented electrodes, where each set is disposed around a circumference of thelead 100 at a particular longitudinal portion of thelead 100. Thelead 100 may have any number segmentedelectrodes 130 in a given set of segmented electrodes. Thelead 100 may have one, two, three, four, five, six, seven, eight, or moresegmented electrodes 130 in a given set. In at least some embodiments, each set ofsegmented electrodes 130 of thelead 100 contains the same number ofsegmented electrodes 130. Thesegmented electrodes 130 disposed on thelead 100 may include a different number of electrodes than at least one other set ofsegmented electrodes 130 disposed on thelead 100. - The
segmented electrodes 130 may vary in size and shape. In some embodiments, thesegmented electrodes 130 are all of the same size, shape, diameter, width or area or any combination thereof. In some embodiments, thesegmented electrodes 130 of each circumferential set (or even all segmented electrodes disposed on the lead 100) may be identical in size and shape. - Each set of
segmented electrodes 130 may be disposed around the circumference of thelead body 110 to form a substantially cylindrical shape around thelead body 110. The spacing between individual electrodes of a given set of the segmented electrodes may be the same, or different from, the spacing between individual electrodes of another set of segmented electrodes on thelead 100. In at least some embodiments, equal spaces, gaps or cutouts are disposed between eachsegmented electrode 130 around the circumference of thelead body 110. In other embodiments, the spaces, gaps or cutouts between thesegmented electrodes 130 may differ in size or shape. In other embodiments, the spaces, gaps, or cutouts betweensegmented electrodes 130 may be uniform for a particular set of thesegmented electrodes 130, or for all sets of thesegmented electrodes 130. The sets ofsegmented electrodes 130 may be positioned in irregular or regular intervals along a length thelead body 110. - Conductor wires that attach to the
ring electrodes 120 orsegmented electrodes 130 extend along thelead body 110. These conductor wires may extend through the material of thelead 100 or along one or more lumens defined by thelead 100, or both. The conductor wires are presented at a connector (via terminals) for coupling of theelectrodes - When the
lead 100 includes bothring electrodes 120 andsegmented electrodes 130, thering electrodes 120 and thesegmented electrodes 130 may be arranged in any suitable configuration. For example, when thelead 100 includes two sets ofring electrodes 120 and two sets ofsegmented electrodes 130, thering electrodes 120 can flank the two sets of segmented electrodes 130 (see e.g.,FIG. 1 ). Alternately, the two sets ofring electrodes 120 can be disposed proximal to the two sets of segmented electrodes 130 (see e.g.,FIG. 3C ), or the two sets ofring electrodes 120 can be disposed distal to the two sets of segmented electrodes 130 (see e.g.,FIG. 3D ). It will be understood that other configurations are possible as well (e.g., alternating ring and segmented electrodes, or the like). - By varying the location of the
segmented electrodes 130, different coverage of the target neurons may be selected. For example, the electrode arrangement ofFIG. 3C may be useful if the physician anticipates that the neural target will be closer to a distal tip of thelead body 110, while the electrode arrangement ofFIG. 3D may be useful if the physician anticipates that the neural target will be closer to a proximal end of thelead body 110. - Any combination of
ring electrodes 120 andsegmented electrodes 130 may be disposed on thelead 100. For example, the lead may include afirst ring electrode 120, two sets of segmented electrodes; each set formed of foursegmented electrodes 130, and afinal ring electrode 120 at the end of the lead. This configuration may simply be referred to as a 1-4-4-1 configuration. It may be useful to refer to the electrodes with this shorthand notation. Thus, the embodiment ofFIG. 3C may be referred to as a 1-1-4-4 configuration, while the embodiment ofFIG. 3D may be referred to as a 4-4-1-1 configuration. Other electrode configurations include, for example, a 2-2-2-2 configuration, where four sets of segmented electrodes are disposed on the lead, and a 4-4 configuration, where two sets of segmented electrodes, each having foursegmented electrodes 130 are disposed on the lead. In some embodiments, the lead includes 16 electrodes. Possible configurations for a 16-electrode lead include, but are not limited to 4-4-4-4; 8-8; 3-3-3-3-3-1 (and all rearrangements of this configuration); and 2-2-2-2-2-2-2-2. -
FIG. 2 is a schematic diagram to illustrate radial current steering along various electrode levels along the length of thelead 200. While conventional lead configurations with ring electrodes are only able to steer current along the length of the lead (the z-axis), the segmented electrode configuration is capable of steering current in the x-axis, y-axis as well as the z-axis. Thus, the centroid of stimulation may be steered in any direction in the three-dimensional space surrounding thelead 200. In some embodiments, the radial distance, r, and the angle θ around the circumference of thelead 200 may be dictated by the percentage of anodic current (recognizing that stimulation predominantly occurs near the cathode, although strong anodes may cause stimulation as well) introduced to each electrode. In at least some embodiments, the configuration of anodes and cathodes along the segmented electrodes allows the centroid of stimulation to be shifted to a variety of different locations along thelead 200. - As can be appreciated from
FIG. 2 , the centroid of stimulation can be shifted at each level along the length of thelead 200. The use of multiple sets of segmented electrodes at different levels along the length of the lead allows for three-dimensional current steering. In some embodiments, the sets of segmented electrodes are shifted collectively (i.e., the centroid of simulation is similar at each level along the length of the lead). In at least some other embodiments, each set of segmented electrodes is controlled independently. Each set of segmented electrodes may contain two, three, four, five, six, seven, eight or more segmented electrodes. It will be understood that different stimulation profiles may be produced by varying the number of segmented electrodes at each level. For example, when each set of segmented electrodes includes only two segmented electrodes, uniformly distributed gaps (inability to stimulate selectively) may be formed in the stimulation profile. In some embodiments, at least three segmented electrodes 230 in a set are utilized to allow for true 360° selectivity. - As previously indicated, the foregoing configurations may also be used while utilizing recording electrodes. In some embodiments, measurement devices coupled to the muscles or other tissues stimulated by the target neurons or a unit responsive to the patient or clinician can be coupled to the control unit or microdrive motor system. The measurement device, user, or clinician can indicate a response by the target muscles or other tissues to the stimulation or recording electrodes to further identify the target neurons and facilitate positioning of the stimulation electrodes. For example, if the target neurons are directed to a muscle experiencing tremors, a measurement device can be used to observe the muscle and indicate changes in tremor frequency or amplitude in response to stimulation of neurons. Alternatively, the patient or clinician may observe the muscle and provide feedback.
- The reliability and durability of the lead will depend heavily on the design and method of manufacture. Fabrication techniques discussed below provide methods that can produce manufacturable and reliable leads.
- Returning to
FIG. 1 , when thelead 100 includes a plurality of sets ofsegmented electrodes 130, it may be desirable to form thelead 100 such that corresponding electrodes of different sets ofsegmented electrodes 130 are radially aligned with one another along the length of the lead 100 (see e.g., thesegmented electrodes 130 shown inFIG. 1 ). Radial alignment between corresponding electrodes of different sets ofsegmented electrodes 130 along the length of thelead 100 may reduce uncertainty as to the location or orientation between corresponding segmented electrodes of different sets of segmented electrodes. Accordingly, it may be beneficial to form electrode arrays such that corresponding electrodes of different sets of segmented electrodes along the length of thelead 100 are radially aligned with one another and do not radially shift in relation to one another during manufacturing of thelead 100. - In other embodiments, individual electrodes in the two sets of
segmented electrodes 130 are staggered relative to one another along the length of thelead body 110. In some cases, the staggered positioning of corresponding electrodes of different sets of segmented electrodes along the length of thelead 100 may be designed for a specific application. - Segmented electrodes can be used to tailor the stimulation region so that, instead of stimulating tissue around the circumference of the lead as would be achieved using a ring electrode, the stimulation region can be directionally targeted. In some instances, it is desirable to target a parallelepiped (or slab)
region 250 that contains the electrodes of thelead 200, as illustrated inFIG. 2 . One arrangement for directing a stimulation field into a parallelepiped region uses segmented electrodes disposed on opposite sides of a lead. -
FIGS. 3A-3D illustrate leads 300 withsegmented electrodes 330,optional ring electrodes 320, and alead body 310. The groups ofsegmented electrodes 330 include either two (FIG. 3B ) or four (FIGS. 3A , 3C, and 3D) segmented electrodes. It will be recognized that other groups of segmented electrodes with an even number of electrodes in the group can also be used. In these embodiments, segmented electrodes on opposite sides of the lead are ganged (i.e., electrically coupled) together, as illustrated schematically by thelines 360. - One arrangement for ganging two segmented electrodes together which includes coupling the two electrodes (for example,
electrodes electrode 330 a) is electrically coupled to a conductor (not shown) that passes through the lead body to the proximal end of the lead to provide for connection to a terminal or contact at the proximal end of the lead and the other electrode (for example,electrode 330 b) is coupled to the first electrode by the conductor represented byline 360. This conductor might be a wire or may be a thin, flat conductor. - In operation, stimulation current is applied through the ganged segmented electrodes (for example,
electrodes electrodes - As illustrated in
FIGS. 3A , 3C, and 3D, multiple pairs of gangedsegmented electrodes 330 can be provided in each group of segmented electrodes. The pairs of gangedsegmented electrodes 330 are radially offset from each other. For example, two pairs may be radially offset by an angle in the range of 75 to 115 degrees or by an angle in the range of 80 to 110 degrees or be an angle of 90 degrees. - As illustrated in
FIG. 3B , the pairs of ganged segmented electrodes can be longitudinally staggered with respect to each other. As illustrated inFIG. 3B , the staggered pairs of ganged segmented electrodes may include electrode portions that are at a same longitudinal position (i.e., the two pairs overlap longitudinally—but not radially). In other embodiments, the electrodes of the staggered pairs do not overlap longitudinally (i.e., no portions of the electrodes of the two pairs have the same longitudinal position on the lead). - Any other suitable arrangements of segmented electrodes (and pairs of ganged segmented electrodes) can be used. As an example, arrangements in which pairs of segmented electrodes are arranged helically with respect to each other. One embodiment includes a double helix with the electrodes at each longitudinal position along the two helices ganged together.
- As an alternative to ganging segmented electrodes together using conductors, the segmented electrodes (or a subset of segmented electrodes) can be coupled to a multiplexer (which is preferably disposed in the lead near the electrodes) or to controllable switches (which are preferably disposed in the lead near the electrodes). The multiplexer or controllable switches can be used to electrically gang segmented electrodes together, but can also be used to change which electrodes are ganged together, if desired.
- Other lead configurations can also be used. For example,
FIGS. 4A and 4B illustrate portions of a lead 400 with alead body 410 having a non-circular cross-section and including two elongated surfaces upon whichelectrodes 430 are disposed. Thislead 400 is sized so that it can be implanted percutaneously using anintroducer 470 such as a percutaneous needle or cannula. - The
lead body 410 can have any suitable non-circular cross-sectional shape including, but not limited to, oval, rectangular, square, or rectangular/square with rounded corners (as illustrated inFIG. 4 ), or the like. In some embodiments, the non-circular cross-sectional shape of the lead extends the entire length of the lead. In other embodiments, the non-circular cross-sectional shape of the lead only extends a portion (for example, a portion including the region near the distal end upon which the electrodes are disposed) of the length of the lead with the remainder of the lead having a circular cross-sectional shape (for example, a portion including the proximal end of the lead). - The
lead body 410 has two opposing surfaces upon whichelectrodes 430 can be disposed. These surfaces may be flat or curved. The electrodes are coupled to terminals (not shown) on the proximal end of the lead by conductors (not shown) that extend along the length of the lead. - The electrodes can be formed using any biocompatible conductive material. Examples of suitable materials include metals, alloys, conductive polymers, conductive carbon, and the like, as well as combinations thereof. In at least some embodiments, one or more of the electrodes are formed from one or more of: platinum, platinum iridium, palladium, titanium nitride, or rhenium.
- The
electrodes 430 can be disposed in an array on each of the surfaces of the lead, as illustrated inFIG. 4B . The number ofelectrodes 430 in the array of electrodes on a particular surface of the lead may vary. For example, there can be two, three, four, five, six, seven, eight, nine, ten, eleven, twelve, thirteen, fourteen, fifteen, sixteen, or more electrodes. As will be recognized, other numbers of electrodes may also be used. Theelectrodes 140 can be formed in any suitable shape including, for example, round, oval, triangular, rectangular, pentagonal, hexagonal, heptagonal, octagonal, or the like. Theelectrodes 430 of an array can be arranged in any arrangement including arrangements with in one or more columns, one or more rows, or both rows and columns (as illustrated inFIG. 4B ). Theelectrodes 430 in a row or column may be aligned with an adjacent row or column or may be staggered with respect to an adjacent row or column. There may be an array ofelectrodes 430 on two opposing sides oflead 400, as illustrated inFIG. 4A . The arrays on the two opposing sides can be the same or different. - The
electrodes 430 are typically disposed in, or separated by, a non-conductive, biocompatible material of thelead body 410 including, for example, silicone, polyurethane, and the like or combinations thereof. Thelead body 410 may be formed in the desired shape by any process including, for example, molding (including injection molding), casting, and the like. Electrodes and connecting wires can be disposed onto or within the lead body either prior to or subsequent to a molding or casting process. - In some embodiments,
electrodes 430 on opposite sides (and, preferably, directly opposite each other) of thelead body 410 can be ganged together in a manner similar to that illustrated for the embodiments ofFIGS. 3A-3D . In some embodiments,electrodes 430 on the same side of the lead body 410 (for example, electrodes in a row or column) can be ganged together. - A lead with a lead body having a non-circular cross-sectional shape and electrodes disposed thereon can be formed using an suitable technique including forming a lead body around electrodes disposed in two sides of a mold. In at least some instances, it may be easier or more economical to form electrodes on one side of a lead body.
FIGS. 6A and 6B illustrate one method for forming alead body 610 having a non-circular cross-sectional shape andelectrodes 630 disposed on opposing sides of the lead body. As illustrated inFIG. 6A , alead body 610 withelectrodes 630 disposed on one side of the lead body is formed. For example, theelectrodes 630 can be attached to conductors (not shown) which can extend along the lead to terminals or contact on a distal end of the lead. Theseelectrodes 630 can be placed in a mold and then thelead body 610 molded around theelectrodes 630 leaving a surface of each electrode exposed. - In these embodiments, the
lead body 610 includes twomain portions 612 divided by abendable portion 614. The electrodes are disposed on the twomain portions 612. In at least some embodiments, thebendable portion 614 has a thickness that is substantially less than a thickness of the two main portions. In some embodiments, thebendable portion 612 may include one or more hinges, one or more holes, one or more reduced-thickness portion, or any other suitable structure that facilitates bending or folding of the bendable portion. - In forming the lead with electrodes on opposing sides, the
bendable portion 614 is bent so that the twomain portions 612 are disposed opposite each other, as illustrated inFIG. 6B . Thislead body 610 can be inserted into anintroducer 670. In some embodiments, thebendable portion 614 contains material that retains the bend once bent. In other embodiments, thebendable portion 614 is resilient and may spring back to its original shape or some intermediate position. Optionally, one or more fasteners (e.g., straps, hooks, and the like), sutures disposed around the lead body, or adhesive may be provided to retain thelead body 610 in the bent shape. In other embodiments, thelead body 610 retains the bent shape once implanted due to the presence of adjacent tissue. - When implanting a lead, particularly in the brain, it can be useful to provide a recording electrode that can be used to identify the tissue that is to be stimulated. In many conventional procedures, a recording electrode lead is inserted into an introducer and the introducer is inserted into the patient. The introducer is then moved through the tissue using the recording electrode to identify which tissue is to be stimulated. Once the desired tissue is identified, the recording electrode lead is removed from the introducer and a stimulating electrode lead is inserted. This conventional procedure can take additional time for removal and insertion of multiple leads. Moreover, the introducer may inadvertently move during removal of the recording electrode lead and the insertion of the stimulating electrode lead which may result in the stimulating electrode lead being no longer aligned with the desired tissue.
- A system can be provided that addresses this issue by providing an introducer and lead that can be used simultaneously with a microelectrode lead.
FIG. 5 illustrates one embodiment of such a system with an introducer 570 (e.g., a cannula or a needle) defining anintroducer lumen 572 into which a stimulation lead 500 (which can correspond to thelead 400 ofFIGS. 4A and 4B ) can be inserted. Within theintroducer lumen 572, one or moremicroelectrode lumens 574 are formed using one ormore walls 582.FIG. 5 illustrates two microelectrode lumens, but in other embodiments only one microelectrode lumen is provided. Amicroelectrode lead 580 can be inserted with eachmicroelectrode lumen 574 formed within theintroducer 570. Themicroelectrode lead 580 includes a microelectrode at a tip of themicroelectrode lead 580 which can be used as a recording electrode to identify tissue to be stimulated. Themicroelectrode lead 580 may be, for example, a guidewire or other suitable lead structure. - The
walls 582 which form themicroelectrode lumens 574 can be cylindrical or any other suitable shape. Thewalls 582 surround the entire lumen (e.g., have a circular cross-section) or may include openings (for example, have a C-shape in cross-section, as illustrated inFIG. 5 ). In some instances, a portion of the wall of the introducer may form part of thewall 582 of themicroelectrode lumens 574. Thewalls 582 may extend the entire length of theintroducer 570 or may only extend partway along the introducer, for example, partway from the distal end or the proximal end or a combination thereof. - The arrangement illustrated in
FIG. 5 allows for theintroducer 570 to contain both the microelectrodes lead(s) 580 and thestimulation lead 500 simultaneously. In some embodiments, both the microelectrode lead(s) 580 and stimulation lead are inserted into the introducer prior to insertion of the introducer into the patient. In other embodiments, the microelectrode lead(s) may be inserted into the introducer prior to, or after, insertion of the introducer into the patient and then the microelectrode lead(s) are used to identify the tissue to be stimulated. Later, the stimulation lead may be inserted into the introducer with the microelectrode lead(s) remaining in the introducer. The microelectrode lead(s) can be used to verify that the stimulation lead is properly positioned after it insertion into the introducer in the patient. - The above specification, examples, and data provide a description of the manufacture and use of the composition of the invention. Since many embodiments of the invention can be made without departing from the spirit and scope of the invention, the invention also resides in the claims hereinafter appended.
Claims (20)
1. A stimulation lead, comprising:
a lead body comprising a longitudinal surface, a distal end, and a proximal end; and
a plurality of electrodes disposed along the longitudinal surface of the lead body near the distal end of the lead body, the plurality of electrodes comprising a plurality of groups of segmented electrodes, each group of segmented electrodes comprising a plurality of segmented electrodes disposed at a same longitudinal position along the lead, wherein, for at least one first group of the plurality of groups of segmented electrodes, a first pair of the segmented electrodes in the first group are disposed on opposite sides of the lead body and are electrically ganged together by a conductor therebetween.
2. The stimulation lead of claim 1 , wherein the first group consists of the first pair of segmented electrodes.
3. The stimulation lead of claim 1 , wherein the first group comprises at least one additional segmented electrode in addition to the first pair of segmented electrodes, wherein the at least one additional segmented electrode is not electrically ganged to the first pair of segmented electrodes.
4. The stimulation lead of claim 3 , wherein the at least one additional segmented electrode comprises a second pair of the segmented electrodes that are disposed on opposite sides of the lead body and are electrically ganged together by a conductor therebetween.
5. The stimulation lead of claim 4 , wherein the first pair and the second pair are radially offset by an angle in a range of 75 to 115 degrees with respect to each other.
6. The stimulation lead of claim 1 , wherein the plurality of groups of segmented electrodes comprises a second group disposed at a different longitudinal position than the first group, the second group comprising a second pair of the segmented electrodes which are disposed on opposite sides of the lead body and are electrically ganged together by a conductor therebetween.
7. The stimulation lead of claim 6 , wherein the first pair and the second pair are radially offset by an angle in a range of 75 to 115 degrees with respect to each other.
8. The stimulation lead of claim 7 , wherein the first pair longitudinally overlaps with the second pair.
9. The stimulation lead of claim 6 , wherein the first and second pairs of the segmented electrodes are radially aligned with each other.
10. The stimulation lead of claim 9 , wherein the first group comprises a third pair of the segmented electrodes which are disposed on opposite sides of the lead body and are electrically ganged together by a conductor therebetween and the second group comprises a fourth pair of the segmented electrodes which are disposed on opposite sides of the lead body and are electrically ganged together by a conductor therebetween.
11. The stimulation lead of claim 10 , wherein the third and fourth pairs of the segmented electrodes are radially aligned with each other.
12. The stimulation lead of claim 1 , wherein the plurality of electrodes further comprises at least one ring electrode.
13. The stimulation lead of claim 1 , further comprising a plurality of terminals disposed along the longitudinal surface of the lead body near the proximal end of the lead body and electrically coupled to the plurality of electrodes.
14. A kit for implanting a stimulation lead into a patient, the kit comprising:
a stimulation lead comprising a longitudinal surface, a distal end, and at least one electrode disposed along the longitudinal surface of the stimulation lead near the distal end of the stimulation lead, wherein a portion of the stimulation lead upon which the electrodes are disposed has a non-circular cross-sectional shape;
at least one microelectrode lead comprising a distal end and at least one microelectrode disposed at the distal end of the microelectrode lead; and
an introducer defining a lumen configured and arranged to receive the stimulation lead, the introducer further comprising at least one interior wall extending into the lumen and defining at least one microelectrode lumen that is configured and arranged to receive, and hold within the microelectrode lumen, a one of the at least one microelectrode leads.
15. The kit of claim 14 , wherein the introducer comprises at least two interior walls defining at least two microelectrode lumens.
16. The kit of claim 14 , wherein the stimulation lead further comprises a proximal end, two main portions disposed at the distal end of the lead, a bendable portion disposed between the two main portions, and a plurality of terminals disposed along the proximal end of the lead and electrically coupled to the plurality of electrodes, wherein the bendable portion is bent so that the two main portions are disposed opposite each other and the plurality of electrodes are disposed on surfaces of the two main portions of the lead, wherein each electrode has an exposed surface through which electrical energy can be supplied to stimulate adjacent tissue when the stimulation lead is implanted.
17. A method for stimulating tissue, the method comprising:
implanting a lead comprising a longitudinal surface, a distal end, a proximal end, two main portions disposed at the distal end of the lead, a bendable portion disposed between the two main portions, a plurality of electrodes disposed on surfaces of the two main portions of the lead, and a plurality of terminals disposed along the proximal end of the lead and electrically coupled to the plurality of electrodes, wherein the bendable portion is bent so that the two main portions are disposed opposite each other and wherein each electrode has an exposed surface through which electrical energy can be supplied to stimulate adjacent tissue when the stimulation lead is implanted;
retaining the lead in the patient with the bendable portion bent; and
stimulating adjacent tissue using at least one of the electrodes.
18. The method of claim 17 , wherein implanting a lead comprising inserting at least the distal end of the lead into an introducer defining a lumen configured and arranged to receive the lead, the introducer further comprising at least one interior wall extending into the lumen and defining at least one microelectrode lumen that is configured and arranged to receive a microelectrode lead.
19. The method of claim 17 , wherein implanting a lead further comprises inserting a microelectrode lead into the microelectrode lumen of the lead body.
20. The method of claim 17 , wherein implanting a lead further comprises using the microelectrode lead to identify tissue for stimulation.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/368,733 US20120203316A1 (en) | 2011-02-08 | 2012-02-08 | Leads with segmented electrodes for electrical stimulation of planar regions and methods of making and using |
US14/517,746 US9283375B2 (en) | 2011-02-08 | 2014-10-17 | Leads with segmented electrodes for electrical stimulation of planar regions and methods of making and using |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161440546P | 2011-02-08 | 2011-02-08 | |
US13/368,733 US20120203316A1 (en) | 2011-02-08 | 2012-02-08 | Leads with segmented electrodes for electrical stimulation of planar regions and methods of making and using |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/517,746 Continuation US9283375B2 (en) | 2011-02-08 | 2014-10-17 | Leads with segmented electrodes for electrical stimulation of planar regions and methods of making and using |
Publications (1)
Publication Number | Publication Date |
---|---|
US20120203316A1 true US20120203316A1 (en) | 2012-08-09 |
Family
ID=46601186
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/368,733 Abandoned US20120203316A1 (en) | 2011-02-08 | 2012-02-08 | Leads with segmented electrodes for electrical stimulation of planar regions and methods of making and using |
US14/517,746 Active US9283375B2 (en) | 2011-02-08 | 2014-10-17 | Leads with segmented electrodes for electrical stimulation of planar regions and methods of making and using |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/517,746 Active US9283375B2 (en) | 2011-02-08 | 2014-10-17 | Leads with segmented electrodes for electrical stimulation of planar regions and methods of making and using |
Country Status (1)
Country | Link |
---|---|
US (2) | US20120203316A1 (en) |
Cited By (175)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110078900A1 (en) * | 2009-07-07 | 2011-04-07 | Boston Scientific Neuromodulation Corporation | Methods for making leads with radially-aligned segmented electrodes for electrical stimulation systems |
US20110130817A1 (en) * | 2009-11-30 | 2011-06-02 | Boston Scientific Neuromodulation Corporation | Electrode array having a rail system and methods of manufacturing the same |
US20110130818A1 (en) * | 2009-11-30 | 2011-06-02 | Boston Scientific Neuromodulation Corporation | Electrode array having concentric split ring electrodes and methods of making the same |
US20130123600A1 (en) * | 2011-11-10 | 2013-05-16 | Neuropace, Inc. | Multimodal Brain Sensing Lead |
US8560074B2 (en) | 2009-11-30 | 2013-10-15 | Boston Scientific Neuromodulation Corporation | Electrode array having concentric windowed cylinder electrodes and methods of making the same |
WO2013177145A1 (en) | 2012-05-25 | 2013-11-28 | Boston Scientific Neuromodulation Corporation | Methods for stimulating the dorsal root ganglion with a lead having segmented electrodes |
WO2013177307A1 (en) | 2012-05-25 | 2013-11-28 | Boston Scientific Neuromodulation Corporation | Percutaneous implantation of an electrical stimulation lead for stimulating dorsal root ganglion |
WO2013177159A1 (en) | 2012-05-25 | 2013-11-28 | Boston Scientific Neuromodulation Corporation | Systems and methods for electrically stimulating patient tissue on or around one or more bony structures |
WO2013181519A2 (en) | 2012-06-01 | 2013-12-05 | Boston Scientific Neuromodulation Corporation | Leads with tip electrode for electrical stimulation systems and methods of making and using |
US8649873B2 (en) | 2009-04-16 | 2014-02-11 | Boston Scientific Neuromodulation Corporation | Deep brain stimulation current steering with split electrodes |
US8666509B2 (en) | 2009-11-30 | 2014-03-04 | Boston Scientific Neuromodulation Corporation | Electrode array with electrodes having cutout portions and methods of making the same |
US8744596B2 (en) | 2012-03-30 | 2014-06-03 | Boston Scientific Neuromodulation Corporation | Leads with X-ray fluorescent capsules for electrode identification and methods of manufacture and use |
US8831742B2 (en) | 2012-01-26 | 2014-09-09 | Boston Scientific Neuromodulation Corporation | Systems and methods for identifying the circumferential positioning of electrodes of leads for electrical stimulation systems |
US8849415B2 (en) | 2006-07-31 | 2014-09-30 | Boston Scientific Neuromodulation Corporation | Multi-channel connector for brain stimulation system |
US8862242B2 (en) | 2010-12-23 | 2014-10-14 | Boston Scientific Neuromodulation Corporation | Methods for making leads with segmented electrodes for electrical stimulation systems |
US8868206B2 (en) | 2010-06-18 | 2014-10-21 | Boston Scientific Neuromodulation Corporation | Electrode array having embedded electrodes and methods of making the same |
US8897891B2 (en) | 2012-08-03 | 2014-11-25 | Boston Scientific Neuromodulation Corporation | Leads with electrode carrier for segmented electrodes and methods of making and using |
US8897889B2 (en) | 2008-10-09 | 2014-11-25 | Boston Scientific Neuromodulation Corporation | Electrode design for leads of implantable electric stimulation systems and methods of making and using |
WO2014193761A1 (en) | 2013-05-31 | 2014-12-04 | Boston Scientific Neuromodulation Corporation | Methods for manufacturing segmented electrode leads using a removable ring and the leads formed thereby |
WO2014193762A2 (en) | 2013-05-31 | 2014-12-04 | Boston Scientific Neuromodulation Corporation | Leads containing segmented electrodes with non-perpendicular legs and methods of making and using |
WO2014193759A1 (en) | 2013-05-31 | 2014-12-04 | Boston Scientific Neuromodulation Corporation | Segmented electrode leads formed from pre-electrodes with alignment features and mehods of making and using the leads |
WO2015006239A1 (en) | 2013-07-12 | 2015-01-15 | Boston Scientific Neuromodulation Corporation | Leads with segmented electrodes and methods of making and using the leads |
WO2015031375A1 (en) | 2013-08-30 | 2015-03-05 | Boston Scientific Neuromodulation Corporation | Methods of making segmented electrode leads using flanged carrier |
WO2015084745A1 (en) | 2013-12-02 | 2015-06-11 | Boston Scientific Neuromodulation Corporation | Electrical stimulation leads with helically arranged electrodes and methods for their manufacture |
US9162048B2 (en) | 2013-05-15 | 2015-10-20 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using tip electrodes for leads of electrical stimulation systems |
US9162049B2 (en) | 2010-09-13 | 2015-10-20 | Boston Scientific Neuromodulation Corporation | Devices and methods for tissue modulation and monitoring |
WO2015192058A1 (en) | 2014-06-13 | 2015-12-17 | Boston Scientific Neuromodulation Corporation | Leads with electrode carriers for segmented electrodes and methods of making and using |
US9248270B2 (en) | 2007-03-19 | 2016-02-02 | Boston Scientific Neuromodulation Corporation | Methods and apparatus for fabricating leads with conductors and related flexible |
US9248272B2 (en) | 2013-05-31 | 2016-02-02 | Boston Scientific Neuromodulation Corporation | Segmented electrode leads formed from pre-electrodes with depressions or apertures and methods of making and using |
US9248276B2 (en) | 2011-02-02 | 2016-02-02 | Boston Scientific Neuromodulation Corporation | Leads with spiral of helical segmented electrode arrays and methods of making and using the leads |
US9248275B2 (en) | 2011-02-08 | 2016-02-02 | Boston Scientific Neuromodulation Corporation | Methods of making leads with retention features for segmented electrodes |
US9270070B2 (en) | 2009-07-07 | 2016-02-23 | Boston Scientific Neuromodulation Corporation | Methods of manufacturing leads with a radially segmented electrode array |
US9283394B2 (en) | 2002-06-20 | 2016-03-15 | Boston Scientific Neuromodulation Corporation | Implantable microstimulators and methods for unidirectional propagation of action potentials |
US9283375B2 (en) | 2011-02-08 | 2016-03-15 | Boston Scientific Neuromodulation Corporation | Leads with segmented electrodes for electrical stimulation of planar regions and methods of making and using |
WO2016049047A2 (en) | 2014-09-22 | 2016-03-31 | Boston Scientific Neuromodulation Corporation | Systems and methods for providing therapy using electrical stimulation to disrupt neuronal activity |
US9302113B2 (en) | 2013-07-29 | 2016-04-05 | Boston Scientific Neuromodulation Corporation | Systems and methods for identifying anode placement based on cerebrospinal fluid thickness |
US9314614B2 (en) | 2006-07-31 | 2016-04-19 | Boston Scientific Neuromodulation Corporation | Lead and methods for brain monitoring and modulation |
US9314208B1 (en) | 2014-10-28 | 2016-04-19 | Biosense Webster (Israel) Ltd. | Basket catheter with microelectrode array distal tip |
WO2016065263A1 (en) * | 2014-10-24 | 2016-04-28 | Medtronic, Inc. | Medical electrical lead |
WO2016073316A1 (en) | 2014-11-03 | 2016-05-12 | Boston Scientific Neuromodulation Corporation | Electrical stimulation system with anchoring stylet and methods of making and using |
US9381348B2 (en) | 2013-05-31 | 2016-07-05 | Boston Scientific Neuromodulation Corporation | Leads with segmented electrodes and methods of making and using the leads |
US9440066B2 (en) | 2014-01-27 | 2016-09-13 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using connector assemblies for implantable medical device systems |
WO2016191436A1 (en) | 2015-05-26 | 2016-12-01 | Boston Scientific Neuromodulation Corporation | Systems and methods for analyzing electrical stimulation and selecting or manipulating volumes of activation |
WO2017011477A1 (en) | 2015-07-16 | 2017-01-19 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using connector contact arrays for electrical stimulation systems |
US9561362B2 (en) | 2014-11-10 | 2017-02-07 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using improved contact arrays for electrical stimulation systems |
US9566747B2 (en) | 2013-07-22 | 2017-02-14 | Boston Scientific Neuromodulation Corporation | Method of making an electrical stimulation lead |
WO2017035158A1 (en) | 2015-08-24 | 2017-03-02 | Boston Scientific Neuromodulation Corporation | Systems and methods for determining orientation of an electrical stimulation lead |
US9604068B2 (en) | 2014-11-10 | 2017-03-28 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using improved connector contacts for electrical stimulation systems |
US9655528B2 (en) | 2013-07-15 | 2017-05-23 | Boston Scientific Neuromodulation Corporation | Systems and methods for detecting cerebrospinal-fluid pulsation using an implantable electrical stimulation device |
WO2017136346A1 (en) | 2016-02-05 | 2017-08-10 | Boston Scientfic Neuromodulation Corporation | Implantable optical stimulation lead |
WO2017143254A1 (en) | 2016-02-19 | 2017-08-24 | Boston Scientific Neuromodulation Corporation | Electrical stimulation cuff devices and systems |
WO2017151438A1 (en) | 2016-02-29 | 2017-09-08 | Boston Scientific Neuromodulation Corporation | Lead anchor for an electrical stimulation system |
US9770598B2 (en) | 2014-08-29 | 2017-09-26 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using improved connector contacts for electrical stimulation systems |
US9795779B2 (en) | 2010-09-21 | 2017-10-24 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using radially-aligned segmented electrodes for leads of electrical stimulation systems |
WO2017201058A1 (en) | 2016-05-17 | 2017-11-23 | Boston Scientific Neuromodulation Corporation | Systems and methods for anchoring a lead for neurostimulation of a target anatomy |
CN107398013A (en) * | 2012-12-24 | 2017-11-28 | 电子运动医疗有限公司 | For arousing the device of continuous contraction of muscle in gastrointestinal organ |
US9827413B2 (en) | 2012-04-17 | 2017-11-28 | Boston Scientific Neuromodulation Corporation | Lead construction for deep brain stimulation |
US9833611B2 (en) | 2015-04-10 | 2017-12-05 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using improved contact arrays for electrical stimulation systems |
US9833622B2 (en) | 2014-09-22 | 2017-12-05 | Boston Scientific Neuromodulation Corporation | Devices and methods using a pathological frequency in electrical stimulation for pain management |
WO2017223505A2 (en) | 2016-06-24 | 2017-12-28 | Boston Scientific Neuromodulation Corporation | Systems and methods for visual analytics of clinical effects |
US9878148B2 (en) | 2012-04-17 | 2018-01-30 | Boston Scientific Neuromodulation Corporation | Lead with contact end conductor guide and methods of making and using |
WO2018022455A1 (en) | 2016-07-29 | 2018-02-01 | Boston Scientific Neuromodulation Corporation | Connector assembly with contact rings comprising biased ball-spring contacts |
WO2018022460A1 (en) | 2016-07-29 | 2018-02-01 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using an electrical stimulation system for peripheral nerve stimulation |
US9901732B2 (en) | 2014-10-24 | 2018-02-27 | Medtronic, Inc. | Medical electrical lead |
US9901737B2 (en) | 2014-09-22 | 2018-02-27 | Boston Scientific Neuromodulation Corporation | Systems and methods for providing therapy to a patient using intermittent electrical stimulation |
WO2018044881A1 (en) | 2016-09-02 | 2018-03-08 | Boston Scientific Neuromodulation Corporation | Systems and methods for visualizing and directing stimulation of neural elements |
US9919148B2 (en) | 2012-05-25 | 2018-03-20 | Boston Scientific Neuromodulation Corporation | Distally curved electrical stimulation lead and methods of making and using |
US9925377B2 (en) | 2014-09-22 | 2018-03-27 | Boston Scientific Neuromodulation Corporation | Systems and methods for providing therapy using electrical stimulation to disrupt neuronal activity |
US9925378B2 (en) | 2014-09-22 | 2018-03-27 | Boston Scientific Neuromodulation Corporation | Devices and methods to use power spectrum or signal association for pain management |
WO2018071420A1 (en) | 2016-10-14 | 2018-04-19 | Boston Scientific Neuromodulation Corporation | Orientation marker for implantable leads, and leads and systems utilizing the orientation marker |
WO2018071842A1 (en) | 2016-10-14 | 2018-04-19 | Boston Scientific Neuromodulation Corporation | Systems and methods for determining orientation of an implanted lead |
WO2018071865A1 (en) | 2016-10-14 | 2018-04-19 | Boston Scientific Neuromodulation Corporation | Systems and methods for closed-loop determination of stimulation parameter settings for an electrical simulation system |
US9956394B2 (en) | 2015-09-10 | 2018-05-01 | Boston Scientific Neuromodulation Corporation | Connectors for electrical stimulation systems and methods of making and using |
US9986989B2 (en) | 2016-01-08 | 2018-06-05 | Boston Scientific Neuromodulation Corporation | Surgical retractor for implanting leads and methods of making and using |
WO2018102773A1 (en) | 2016-12-02 | 2018-06-07 | Boston Scientific Neuromodulation Corporation | Methods and systems for selecting stimulation parameters for electrical stimulation devices |
US10016591B2 (en) | 2014-10-24 | 2018-07-10 | Medtronic, Inc. | Medical electrical lead |
WO2018128949A1 (en) | 2017-01-03 | 2018-07-12 | Boston Scientific Neuromodulation Corporation | Systems and methods for selecting mri-compatible stimulation parameters |
WO2018132334A1 (en) | 2017-01-10 | 2018-07-19 | Boston Scientific Neuromodulation Corporation | Systems and methods for creating stimulation programs based on user-defined areas or volumes |
WO2018132367A1 (en) | 2017-01-10 | 2018-07-19 | Boston Scientific Neuromodulation Corporation | Patterned stimulation for deep brain stimulation |
WO2018160495A1 (en) | 2017-02-28 | 2018-09-07 | Boston Scientific Neuromodulation Corporation | Toolless connector for latching stimulation leads and methods of making and using |
US10071249B2 (en) | 2015-10-09 | 2018-09-11 | Boston Scientific Neuromodulation Corporation | System and methods for clinical effects mapping for directional stimulation leads |
WO2018187090A1 (en) | 2017-04-03 | 2018-10-11 | Boston Scientific Neuromodulation Corporation | Systems and methods for estimating a volume of activation using a compressed database of threshold values |
US10124161B2 (en) | 2016-03-31 | 2018-11-13 | Boston Scientific Neuromodulation Corporation | Neurostimulation lead with conductive elements and methods for making the same |
WO2018217497A1 (en) | 2017-05-22 | 2018-11-29 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using a lead introducer for an electrical stimulation system |
WO2019005684A1 (en) | 2017-06-26 | 2019-01-03 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using implantable optical stimulation leads and assemblies |
WO2019005689A1 (en) | 2017-06-26 | 2019-01-03 | Boston Scientific Neuromodulation Corporation | Systems and methods for visualizing and controlling optogenetic stimulation using optical stimulation systems |
WO2019014224A1 (en) | 2017-07-14 | 2019-01-17 | Boston Scientific Neuromodulation Corporation | Systems and methods for estimating clinical effects of electrical stimulation |
WO2019014217A1 (en) | 2017-07-14 | 2019-01-17 | Boston Scientific Neuromodulation Corporation | Systems and methods for planning and programming electrical stimulation |
WO2019023067A1 (en) | 2017-07-25 | 2019-01-31 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using an enhanced connector of an electrical stimulation system |
US10201713B2 (en) | 2016-06-20 | 2019-02-12 | Boston Scientific Neuromodulation Corporation | Threaded connector assembly and methods of making and using the same |
WO2019036180A1 (en) | 2017-08-15 | 2019-02-21 | Boston Scientific Neuromodulation Corporation | Systems and methods for controlling electrical stimulation using multiple stimulation fields |
US10232169B2 (en) | 2015-07-23 | 2019-03-19 | Boston Scientific Neuromodulation Corporation | Burr hole plugs for electrical stimulation systems and methods of making and using |
WO2019055837A1 (en) | 2017-09-15 | 2019-03-21 | Boston Scientific Neuromodulation Corporation | Actuatable lead connector for an operating room cable assembly and methods of making and using |
US10265531B2 (en) | 2015-09-01 | 2019-04-23 | Boston Scientific Neuromodulation Corporation | Detection of lead orientation |
US10286205B2 (en) | 2015-02-06 | 2019-05-14 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using improved contact arrays for electrical stimulation systems |
WO2019094786A1 (en) | 2017-11-13 | 2019-05-16 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using a low-profile control module for an electrical stimulation system |
WO2019099887A1 (en) | 2017-11-17 | 2019-05-23 | Boston Scientific Neuromodulation Corporation | Systems and methods for generating intermittent stimulation using electrical stimulation systems |
US10307602B2 (en) | 2016-07-08 | 2019-06-04 | Boston Scientific Neuromodulation Corporation | Threaded connector assembly and methods of making and using the same |
US10342983B2 (en) | 2016-01-14 | 2019-07-09 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using connector contact arrays for electrical stimulation systems |
WO2019139883A1 (en) | 2018-01-11 | 2019-07-18 | Boston Scientific Neuromodulation Corporation | Methods and systems for stimulation for glial modulation |
WO2019143574A1 (en) | 2018-01-16 | 2019-07-25 | Boston Scientific Neuromodulation Corporation | An electrical stimulation system with a case-neutral battery and a control module for such a system |
US10391307B2 (en) | 2007-03-19 | 2019-08-27 | Boston Scientific Neuromodulation Corporation | MRI and RF compatible leads and related methods of operating and fabricating leads |
WO2019173281A1 (en) | 2018-03-09 | 2019-09-12 | Boston Scientific Neuromodulation Corporation | Burr hole plugs for electrical stimulation systems |
US10413737B2 (en) | 2015-09-25 | 2019-09-17 | Boston Scientific Neuromodulation Corporation | Systems and methods for providing therapy using electrical stimulation to disrupt neuronal activity |
WO2019178145A1 (en) | 2018-03-16 | 2019-09-19 | Boston Scientific Neuromodulation Corporation | Kits and methods for securing a burr hole plugs for stimulation systems |
WO2019183054A1 (en) | 2018-03-23 | 2019-09-26 | Boston Scientific Neuromodulation Corporation | Optical stimulation systems with calibration and methods of making and using |
WO2019183068A1 (en) | 2018-03-23 | 2019-09-26 | Boston Scientific Neuromodulation Corporation | An optical stimulation system with on-demand monitoring and methods of making and using |
WO2019183082A1 (en) | 2018-03-23 | 2019-09-26 | Boston Scientific Neuromodulation Corporation | Implantable prostheses for reducing visibility of bulging from implanted medical devices |
WO2019183075A1 (en) | 2018-03-23 | 2019-09-26 | Boston Scientific Neuromodulation Corporation | An optical stimulation system with automated monitoring and methods of making and using |
WO2019183078A1 (en) | 2018-03-23 | 2019-09-26 | Boston Scientific Neuromodulation Corporation | Optical stimulation systems using therapy cycling and methods of using |
US10441800B2 (en) | 2015-06-29 | 2019-10-15 | Boston Scientific Neuromodulation Corporation | Systems and methods for selecting stimulation parameters by targeting and steering |
WO2019210214A1 (en) | 2018-04-27 | 2019-10-31 | Boston Scientific Neuromodulation Corporation | Systems for visualizing and programming electrical stimulation |
WO2019210202A1 (en) | 2018-04-27 | 2019-10-31 | Boston Scientific Neuromodulation Corporation | Multi-mode electrical stimulation systems and methods of making and using |
WO2019217415A1 (en) | 2018-05-11 | 2019-11-14 | Boston Scientific Neuromodulation Corporation | Connector assembly for an electrical stimulation system |
US10493269B2 (en) | 2016-06-02 | 2019-12-03 | Boston Scientific Neuromodulation Corporation | Leads for electrostimulation of peripheral nerves and other targets |
US10532206B2 (en) | 2014-10-24 | 2020-01-14 | Medtronic, Inc. | Coronary sinus medical electrical lead |
WO2020014083A1 (en) | 2018-07-09 | 2020-01-16 | Boston Scientific Neuromodulation Corporation | Directional electrical stimulation leads and systems for spinal cord stimulation |
US10543374B2 (en) | 2016-09-30 | 2020-01-28 | Boston Scientific Neuromodulation Corporation | Connector assemblies with bending limiters for electrical stimulation systems and methods of making and using same |
US10576269B2 (en) | 2017-01-03 | 2020-03-03 | Boston Scientific Neuromodulation Corporation | Force-decoupled and strain relieving lead and methods of making and using |
US10603485B2 (en) | 2016-11-28 | 2020-03-31 | Boston Scientific Neuromodulation Corporation | Features in increased surface area on neuromodulation leads |
US10603499B2 (en) | 2017-04-07 | 2020-03-31 | Boston Scientific Neuromodulation Corporation | Tapered implantable lead and connector interface and methods of making and using |
US10625072B2 (en) | 2016-10-21 | 2020-04-21 | Boston Scientific Neuromodulation Corporation | Electrical stimulation methods with optical observation and devices therefor |
US10625082B2 (en) | 2017-03-15 | 2020-04-21 | Boston Scientific Neuromodulation Corporation | Visualization of deep brain stimulation efficacy |
US10631937B2 (en) | 2017-04-14 | 2020-04-28 | Boston Scientific Neuromodulation Corporation | Systems and methods for determining orientation of an implanted electrical stimulation lead |
WO2020102039A1 (en) | 2018-11-16 | 2020-05-22 | Boston Scientific Neuromodulation Corporation | An optical stimulation system with on-demand monitoring and methods of making |
US10709886B2 (en) | 2017-02-28 | 2020-07-14 | Boston Scientific Neuromodulation Corporation | Electrical stimulation leads and systems with elongate anchoring elements and methods of making and using |
US10716942B2 (en) | 2016-04-25 | 2020-07-21 | Boston Scientific Neuromodulation Corporation | System and methods for directional steering of electrical stimulation |
US10716935B2 (en) | 2016-11-04 | 2020-07-21 | Boston Scientific Neuromodulation Corporation | Electrical stimulation leads, systems and methods for stimulation of dorsal root ganglia |
WO2020172071A2 (en) | 2019-02-19 | 2020-08-27 | Boston Scientific Neuromodulation Corporation | Lead introducers and systems and methods including the lead introducers |
US10780274B2 (en) | 2016-08-22 | 2020-09-22 | Boston Scientific Neuromodulation Corporation | Systems and methods for delivering spinal cord stimulation therapy |
US10780282B2 (en) | 2016-09-20 | 2020-09-22 | Boston Scientific Neuromodulation Corporation | Systems and methods for steering electrical stimulation of patient tissue and determining stimulation parameters |
WO2020205843A1 (en) | 2019-04-01 | 2020-10-08 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using a low-profile control module for an electrical stimulation system |
US10835739B2 (en) | 2017-03-24 | 2020-11-17 | Boston Scientific Neuromodulation Corporation | Electrical stimulation leads and systems with elongate anchoring elements and methods of making and using |
WO2020243096A1 (en) | 2019-05-30 | 2020-12-03 | Boston Scientific Neuromodulation Corporation | Methods and systems for discrete measurement of electrical characteristics |
US10857351B2 (en) | 2017-04-28 | 2020-12-08 | Boston Scientific Neuromodulation Corporation | Lead anchors for electrical stimulation leads and systems and methods of making and using |
WO2020257705A1 (en) | 2019-06-20 | 2020-12-24 | Boston Scientific Neuromodulation Corporation | Methods and systems for interleaving waveforms for electrical stimulation and measurement |
US10905871B2 (en) | 2017-01-27 | 2021-02-02 | Boston Scientific Neuromodulation Corporation | Lead assemblies with arrangements to confirm alignment between terminals and contacts |
WO2021021659A1 (en) | 2019-07-26 | 2021-02-04 | Boston Scientific Neuromodulation Corporation | Methods and systems for storage, retrieval, and visualization of signals and signal features |
WO2021021662A1 (en) | 2019-07-26 | 2021-02-04 | Boston Scientific Neuromodulation Corporation | Methods and systems for making electrical stimulation adjustments based on patient-specific factors |
US10967192B2 (en) | 2017-12-29 | 2021-04-06 | Boston Scientific Neuromodulation Corporation | Systems and methods for charging a medical device implanted into a patient |
US11045656B2 (en) | 2017-09-15 | 2021-06-29 | Boston Scientific Neuromodulation Corporation | Biased lead connector for operating room cable assembly and methods of making and using |
WO2021167946A1 (en) | 2020-02-19 | 2021-08-26 | Boston Scientific Neuromodulation Corporation | Methods and systems for treatment of insomnia using deep brain stimulation |
US11103712B2 (en) | 2018-01-16 | 2021-08-31 | Boston Scientific Neuromodulation Corporation | Connector assemblies with novel spacers for electrical stimulation systems and methods of making and using same |
US11139603B2 (en) | 2017-10-03 | 2021-10-05 | Boston Scientific Neuromodulation Corporation | Connectors with spring contacts for electrical stimulation systems and methods of making and using same |
US11160981B2 (en) | 2015-06-29 | 2021-11-02 | Boston Scientific Neuromodulation Corporation | Systems and methods for selecting stimulation parameters based on stimulation target region, effects, or side effects |
US11167128B2 (en) | 2018-11-16 | 2021-11-09 | Boston Scientific Neuromodulation Corporation | Directional electrical stimulation leads, systems and methods for spinal cord stimulation |
US11172959B2 (en) | 2018-05-02 | 2021-11-16 | Boston Scientific Neuromodulation Corporation | Long, flexible sheath and lead blank and systems and methods of making and using |
US11219759B2 (en) | 2017-08-29 | 2022-01-11 | Boston Scientific Neuromodulation Corporation | Systems and methods for introducing an electrical stimulation lead into a patient |
US11224743B2 (en) | 2018-09-21 | 2022-01-18 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using modular leads for electrical stimulation systems |
WO2022051295A1 (en) | 2020-09-04 | 2022-03-10 | Boston Scientific Neuromodulation Corporation | Stimulation systems with a lens arrangement for light coupling and methods of making and using |
US11311726B2 (en) | 2013-03-15 | 2022-04-26 | Boston Scientific Neuromodulation Corporation | Neuromodulation system and method for transitioning between programming modes |
WO2022098554A1 (en) | 2020-11-04 | 2022-05-12 | Boston Scientific Neuromodulation Corporation | Methods and systems for managing access to implantable medical devices |
WO2022103590A1 (en) | 2020-11-11 | 2022-05-19 | Boston Scientific Neuromodulation Corporation | Voice command handler for programming stimulation systems and methods of using |
US11357992B2 (en) | 2019-05-03 | 2022-06-14 | Boston Scientific Neuromodulation Corporation | Connector assembly for an electrical stimulation system and methods of making and using |
US11357544B2 (en) | 2018-01-25 | 2022-06-14 | Boston Scientific Neuromodulation Corporation | Systems and methods for introducing a stimulation lead into a patient |
WO2022159375A1 (en) | 2021-01-19 | 2022-07-28 | Boston Scientific Neuromodulation Corporation | Electrical stimulation cuff devices and systems with directional electrode configurations |
WO2022182892A1 (en) | 2021-02-25 | 2022-09-01 | Boston Scientific Neuromodulation Corporation | Methods and systems for deep brain stimulation of the nucleus basalis of meynert |
WO2022216844A1 (en) | 2021-04-08 | 2022-10-13 | Boston Scientific Neuromodulation Corporation | Photobiomodulation system and delivery device |
WO2022232036A1 (en) | 2021-04-27 | 2022-11-03 | Boston Scientific Neuromodulation Corporation | Systems and methods for automated programming of electrical stimulation |
WO2022245931A1 (en) | 2021-05-21 | 2022-11-24 | Boston Scientific Neuromodulation Corporation | Electrical stimulation cuff devices and systems with helical arrangement of electrodes |
WO2022261004A1 (en) | 2021-06-07 | 2022-12-15 | Boston Scientific Neuromodulation Corporation | Methods and systems for charge balancing of electrical stimulation |
WO2022261001A1 (en) | 2021-06-07 | 2022-12-15 | Boston Scientific Neuromodulation Corporation | Stimulation systems with user-specified routines and methods of making and using |
WO2022265977A1 (en) | 2021-06-15 | 2022-12-22 | Boston Scientific Neuromodulation Corporation | Methods and systems for estimating neural activation by stimulation using a stimulation system |
WO2023107444A1 (en) | 2021-12-10 | 2023-06-15 | Boston Scientific Neuromodulation Corporation | Methods and systems for determining and using an intensity index for electrical stimulation |
WO2023107449A2 (en) | 2021-12-10 | 2023-06-15 | Boston Scientific Neuromodulation Corporation | Systems and methods for generating and using response maps for electrical stimulation |
WO2023107457A2 (en) | 2021-12-09 | 2023-06-15 | Boston Scientific Neuromodulation Corparation | Methods and systems for monitoring or assessing movement disorders or other physiological parameters using a stimulation system |
WO2023154346A1 (en) | 2022-02-10 | 2023-08-17 | Boston Scientific Neuromodulation Corporation | Automatic therapy adjustment based on sensors |
WO2023163882A1 (en) | 2022-02-24 | 2023-08-31 | Boston Scientific Neuromodulation Corporation | Systems and methods for using cost parameters for programming electrical stimulation |
WO2023167872A1 (en) | 2022-03-02 | 2023-09-07 | Boston Scientific Neuromodulation Corporation | Systems and methods for monitoring stimulation drift in an electrical stimulation system |
WO2024044048A1 (en) | 2022-08-22 | 2024-02-29 | Boston Scientific Neuromodulation Corporation | Photobiomodulation systems including an electrode disposed on or over a light emitter and methods of making and using |
WO2024044050A1 (en) | 2022-08-22 | 2024-02-29 | Boston Scientific Neuromodulation Corporation | Implantable photobiomodulation systems employing thermal monitoring or control and methods of making and using |
EP4368242A1 (en) | 2022-11-14 | 2024-05-15 | Boston Scientific Neuromodulation Corporation | Systems and methods for generating and using stimulation programs with temporal variation |
WO2024129609A1 (en) | 2022-12-14 | 2024-06-20 | Boston Scientific Neuromodulation Corporation | Systems and methods for monitoring and revising electrical stimulation |
WO2024141768A2 (en) | 2022-12-29 | 2024-07-04 | Benabid Alim Louis | Optical stimulation systems and methods for implanting and using |
EP4398258A2 (en) | 2023-01-04 | 2024-07-10 | Boston Scientific Neuromodulation Corporation | Systems and methods incorporating a light therapy user interface for optical modulation |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6656211B1 (en) | 2000-10-26 | 2003-12-02 | Scimed Life Systems, Inc. | Stent delivery system with improved tracking |
EP3536376A1 (en) | 2008-07-30 | 2019-09-11 | Ecole Polytechnique Fédérale de Lausanne | Apparatus for optimized stimulation of a neurological target |
CA2743575C (en) | 2008-11-12 | 2017-01-31 | Ecole Polytechnique Federale De Lausanne | Microfabricated neurostimulation device |
SG184395A1 (en) | 2010-04-01 | 2012-11-29 | Ecole Polytech | Device for interacting with neurological tissue and methods of making and using the same |
EP3142745B1 (en) | 2014-05-16 | 2018-12-26 | Aleva Neurotherapeutics SA | Device for interacting with neurological tissue |
US11311718B2 (en) | 2014-05-16 | 2022-04-26 | Aleva Neurotherapeutics Sa | Device for interacting with neurological tissue and methods of making and using the same |
US9925376B2 (en) | 2014-08-27 | 2018-03-27 | Aleva Neurotherapeutics | Treatment of autoimmune diseases with deep brain stimulation |
US9474894B2 (en) | 2014-08-27 | 2016-10-25 | Aleva Neurotherapeutics | Deep brain stimulation lead |
US10702692B2 (en) | 2018-03-02 | 2020-07-07 | Aleva Neurotherapeutics | Neurostimulation device |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7047084B2 (en) * | 2002-11-20 | 2006-05-16 | Advanced Neuromodulation Systems, Inc. | Apparatus for directionally stimulating nerve tissue |
US20070112403A1 (en) * | 2005-11-16 | 2007-05-17 | Moffitt Michael A | Electrode contact configurations for an implantable stimulator |
US20100268298A1 (en) * | 2009-04-16 | 2010-10-21 | Boston Scientific Neuromodulation Corporation | Deep brain stimulation current steering with split electrodes |
Family Cites Families (107)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4630611A (en) | 1981-02-02 | 1986-12-23 | Medtronic, Inc. | Orthogonally-sensing lead |
US4602624A (en) | 1984-10-11 | 1986-07-29 | Case Western Reserve University | Implantable cuff, method of manufacture, and method of installation |
US4744370A (en) | 1987-04-27 | 1988-05-17 | Cordis Leads, Inc. | Lead assembly with selectable electrode connection |
US5000194A (en) | 1988-08-25 | 1991-03-19 | Cochlear Corporation | Array of bipolar electrodes |
US5135001A (en) | 1990-12-05 | 1992-08-04 | C. R. Bard, Inc. | Ultrasound sheath for medical diagnostic instruments |
EP0580928A1 (en) | 1992-07-31 | 1994-02-02 | ARIES S.r.l. | A spinal electrode catheter |
ZA948393B (en) | 1993-11-01 | 1995-06-26 | Polartechnics Ltd | Method and apparatus for tissue type recognition |
US5458629A (en) | 1994-02-18 | 1995-10-17 | Medtronic, Inc. | Implantable lead ring electrode and method of making |
US5522874A (en) | 1994-07-28 | 1996-06-04 | Gates; James T. | Medical lead having segmented electrode |
AU2067597A (en) | 1996-03-07 | 1997-09-22 | Axon Engineering, Inc. | Polymer-metal foil structure for neural stimulating electrodes |
US5713922A (en) | 1996-04-25 | 1998-02-03 | Medtronic, Inc. | Techniques for adjusting the locus of excitation of neural tissue in the spinal cord or brain |
US5711316A (en) | 1996-04-30 | 1998-01-27 | Medtronic, Inc. | Method of treating movement disorders by brain infusion |
US5843148A (en) | 1996-09-27 | 1998-12-01 | Medtronic, Inc. | High resolution brain stimulation lead and method of use |
US5938688A (en) | 1997-10-22 | 1999-08-17 | Cornell Research Foundation, Inc. | Deep brain stimulation method |
US5957966A (en) * | 1998-02-18 | 1999-09-28 | Intermedics Inc. | Implantable cardiac lead with multiple shape memory polymer structures |
US6161047A (en) | 1998-04-30 | 2000-12-12 | Medtronic Inc. | Apparatus and method for expanding a stimulation lead body in situ |
US6134478A (en) | 1998-06-05 | 2000-10-17 | Intermedics Inc. | Method for making cardiac leads with zone insulated electrodes |
US6322559B1 (en) | 1998-07-06 | 2001-11-27 | Vnus Medical Technologies, Inc. | Electrode catheter having coil structure |
US6018684A (en) | 1998-07-30 | 2000-01-25 | Cardiac Pacemakers, Inc. | Slotted pacing/shocking electrode |
JP2003524452A (en) | 1998-12-23 | 2003-08-19 | ヌバシブ, インコーポレイテッド | Nerve monitoring cannula system |
US6564078B1 (en) | 1998-12-23 | 2003-05-13 | Nuvasive, Inc. | Nerve surveillance cannula systems |
US6216045B1 (en) | 1999-04-26 | 2001-04-10 | Advanced Neuromodulation Systems, Inc. | Implantable lead and method of manufacture |
US6167311A (en) | 1999-06-14 | 2000-12-26 | Electro Core Techniques, Llc | Method of treating psychological disorders by brain stimulation within the thalamus |
US6556873B1 (en) * | 1999-11-29 | 2003-04-29 | Medtronic, Inc. | Medical electrical lead having variable bending stiffness |
WO2001058520A1 (en) | 2000-02-09 | 2001-08-16 | Transneuronix, Inc. | Medical implant device for electrostimulation using discrete micro-electrodes |
US6510347B2 (en) | 2000-08-17 | 2003-01-21 | William N. Borkan | Spinal cord stimulation leads |
US6757970B1 (en) | 2000-11-07 | 2004-07-06 | Advanced Bionics Corporation | Method of making multi-contact electrode array |
US7212867B2 (en) | 2000-12-07 | 2007-05-01 | Medtronic, Inc. | Directional brain stimulation and recording leads |
GB0104982D0 (en) | 2001-02-28 | 2001-04-18 | Gill Steven | Electrode |
US6678564B2 (en) | 2001-12-06 | 2004-01-13 | Advanced Cochlear Systems, Inc. | Bio-implant and method of making the same |
US8000802B2 (en) | 2002-04-22 | 2011-08-16 | Medtronic, Inc. | Implantable lead with coplanar contact coupling |
US7027852B2 (en) | 2002-05-21 | 2006-04-11 | Pacesetter, Inc. | Lead with distal tip surface electrodes connected in parallel |
US7292890B2 (en) | 2002-06-20 | 2007-11-06 | Advanced Bionics Corporation | Vagus nerve stimulation via unidirectional propagation of action potentials |
US7203548B2 (en) | 2002-06-20 | 2007-04-10 | Advanced Bionics Corporation | Cavernous nerve stimulation via unidirectional propagation of action potentials |
US7860570B2 (en) | 2002-06-20 | 2010-12-28 | Boston Scientific Neuromodulation Corporation | Implantable microstimulators and methods for unidirectional propagation of action potentials |
US20040215301A1 (en) * | 2003-04-23 | 2004-10-28 | Lokhoff Nicolaas M. | Medical lead with a pivotal tip |
US20050038489A1 (en) | 2003-08-14 | 2005-02-17 | Grill Warren M. | Electrode array for use in medical stimulation and methods thereof |
US8147486B2 (en) | 2003-09-22 | 2012-04-03 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Medical device with flexible printed circuit |
US8224456B2 (en) | 2003-11-25 | 2012-07-17 | Advanced Neuromodulation Systems, Inc. | Directional stimulation lead and orientation system |
US7489971B1 (en) | 2004-06-05 | 2009-02-10 | Advanced Neuromodulation Systems, Inc. | Notched electrode for electrostimulation lead |
WO2006015087A2 (en) | 2004-07-27 | 2006-02-09 | The Cleveland Clinic Foundation | Thalamic stimulation device |
EP1833551B1 (en) | 2004-12-22 | 2013-02-27 | Proteus Digital Health, Inc. | Implantable addressable segmented electrodes |
US20080077186A1 (en) | 2006-04-18 | 2008-03-27 | Proteus Biomedical, Inc. | High phrenic, low capture threshold pacing devices and methods |
US7809446B2 (en) | 2005-01-05 | 2010-10-05 | Boston Scientific Neuromodulation Corporation | Devices and methods for brain stimulation |
US8066702B2 (en) | 2005-01-11 | 2011-11-29 | Rittman Iii William J | Combination electrical stimulating and infusion medical device and method |
US8019439B2 (en) | 2005-01-11 | 2011-09-13 | Boston Scientific Neuromodulation Corporation | Lead assembly and method of making same |
DE602006010515D1 (en) | 2005-01-31 | 2009-12-31 | Medtronic Inc | METHOD FOR PRODUCING A MEDICAL LINE |
US8565898B2 (en) | 2005-04-28 | 2013-10-22 | Medtronic, Inc. | Rate control during AF using cellular intervention to modulate AV node |
US7822482B2 (en) | 2005-07-29 | 2010-10-26 | Medtronic, Inc. | Electrical stimulation lead with rounded array of electrodes |
US8700178B2 (en) | 2005-12-27 | 2014-04-15 | Boston Scientific Neuromodulation Corporation | Stimulator leads and methods for lead fabrication |
US7848802B2 (en) | 2006-02-24 | 2010-12-07 | Medtronic, Inc. | Programming interface with a concentric axial view of a stimulation lead with complex electrode array geometry |
US7822483B2 (en) | 2006-02-24 | 2010-10-26 | Medtronic, Inc. | Electrical and activation field models for configuring stimulation therapy |
EP1993658B1 (en) | 2006-03-02 | 2009-10-07 | St Jude Medical AB | A medical implantable lead and a method for manufacturing of the same |
US8321025B2 (en) | 2006-07-31 | 2012-11-27 | Cranial Medical Systems, Inc. | Lead and methods for brain monitoring and modulation |
ES2699474T3 (en) | 2006-08-07 | 2019-02-11 | Alpha Omega Neuro Tech Ltd | Brain electrodes |
WO2008038208A2 (en) | 2006-09-26 | 2008-04-03 | Koninklijke Philips Electronics, N.V. | Tissue stimulation method and apparatus |
KR101441349B1 (en) | 2006-10-31 | 2014-09-18 | 가부시키가이샤 한도오따이 에네루기 켄큐쇼 | Semiconductor device |
US20080103580A1 (en) | 2006-10-31 | 2008-05-01 | Medtronic, Inc. | Implantable medical elongated member with dual purpose conduit |
US7684873B2 (en) | 2006-10-31 | 2010-03-23 | Medtronic, Inc. | Implantable medical lead including a directional electrode and fixation elements along an interior surface |
US20080114230A1 (en) | 2006-11-14 | 2008-05-15 | Bruce Addis | Electrode support |
US7979140B2 (en) | 2006-12-12 | 2011-07-12 | Alfred E. Mann Foundation For Scientific Research | Segmented electrode |
WO2008072125A1 (en) | 2006-12-13 | 2008-06-19 | Koninklijke Philips Electronics, N.V. | First time right placement of a dbs lead |
WO2008107815A1 (en) | 2007-03-02 | 2008-09-12 | Koninklijke Philips Electronics N.V. | Electrode system for deep brain stimulation |
US7668601B2 (en) | 2007-04-26 | 2010-02-23 | Medtronic, Inc. | Implantable medical lead with multiple electrode configurations |
EP2195081A1 (en) | 2007-08-20 | 2010-06-16 | Medtronic, INC. | Electrode configurations for directional leads |
US9192409B2 (en) | 2008-01-23 | 2015-11-24 | Boston Scientific Neuromodulation Corporation | Steerable stylet handle assembly |
US9220889B2 (en) | 2008-02-11 | 2015-12-29 | Intelect Medical, Inc. | Directional electrode devices with locating features |
US8019440B2 (en) | 2008-02-12 | 2011-09-13 | Intelect Medical, Inc. | Directional lead assembly |
US8600518B2 (en) | 2008-04-30 | 2013-12-03 | Boston Scientific Neuromodulation Corporation | Electrodes for stimulation leads and methods of manufacture and use |
US8688235B1 (en) | 2008-07-22 | 2014-04-01 | Boston Scientific Neuromodulation Corporation | Lead with transition and methods of manufacture and use |
US20100076535A1 (en) | 2008-09-25 | 2010-03-25 | Boston Scientific Neuromodulation Corporation | Leads with non-circular-shaped distal ends for brain stimulation systems and methods of making and using |
US8335551B2 (en) | 2008-09-29 | 2012-12-18 | Chong Il Lee | Method and means for connecting a large number of electrodes to a measuring device |
US8359107B2 (en) | 2008-10-09 | 2013-01-22 | Boston Scientific Neuromodulation Corporation | Electrode design for leads of implantable electric stimulation systems and methods of making and using |
CA2743575C (en) | 2008-11-12 | 2017-01-31 | Ecole Polytechnique Federale De Lausanne | Microfabricated neurostimulation device |
JP2012508624A (en) | 2008-11-13 | 2012-04-12 | プロテウス バイオメディカル インコーポレイテッド | Multiplexed multiple electrode nerve stimulator |
US8250755B2 (en) | 2009-04-24 | 2012-08-28 | Advanced Neuromodulation Systems, Inc. | Process for fabricating a medical lead |
US8225504B2 (en) | 2009-04-24 | 2012-07-24 | Advanced Neuromodulation Systems, Inc. | Medical leads with segmented electrodes and methods of fabrication thereof |
US8046909B2 (en) | 2009-04-24 | 2011-11-01 | Advanced Neuromodulation Systems, Inc. | Method of fabricating stimulation lead |
US20100287770A1 (en) | 2009-05-14 | 2010-11-18 | Cochlear Limited | Manufacturing an electrode carrier for an implantable medical device |
US8887387B2 (en) | 2009-07-07 | 2014-11-18 | Boston Scientific Neuromodulation Corporation | Methods of manufacture of leads with a radially segmented electrode array |
US8875391B2 (en) | 2009-07-07 | 2014-11-04 | Boston Scientific Neuromodulation Corporation | Methods for making leads with radially-aligned segmented electrodes for electrical stimulation systems |
US20110047795A1 (en) | 2009-09-01 | 2011-03-03 | Kevin Turner | Medical leads with segmented electrodes and methods of fabrication thereof |
US20110077699A1 (en) | 2009-09-30 | 2011-03-31 | John Swanson | Medical leads with segmented electrodes and methods of fabrication thereof |
US8874232B2 (en) | 2009-11-30 | 2014-10-28 | Boston Scientific Neuromodulation Corporation | Electrode array having concentric split ring electrodes and methods of making the same |
US8788063B2 (en) | 2009-11-30 | 2014-07-22 | Boston Scientific Neuromodulation Corporation | Electrode array having a rail system and methods of manufacturing the same |
US8295944B2 (en) | 2009-11-30 | 2012-10-23 | Boston Scientific Neuromodulation Corporation | Electrode array with electrodes having cutout portions and methods of making the same |
US8391985B2 (en) | 2009-11-30 | 2013-03-05 | Boston Scientific Neuromodulation Corporation | Electrode array having concentric windowed cylinder electrodes and methods of making the same |
US8571665B2 (en) | 2010-03-23 | 2013-10-29 | Boston Scientific Neuromodulation Corporation | Helical radial spacing of contacts on a cylindrical lead |
JP5834065B2 (en) | 2010-04-02 | 2015-12-16 | ボストン サイエンティフィック ニューロモデュレイション コーポレイション | Directional lead wire assembly |
US8868206B2 (en) | 2010-06-18 | 2014-10-21 | Boston Scientific Neuromodulation Corporation | Electrode array having embedded electrodes and methods of making the same |
WO2012009181A2 (en) | 2010-07-16 | 2012-01-19 | Boston Scientific Neuromodulation Corporation | Systems and methods for radial steering of electrode arrays |
US20120046710A1 (en) | 2010-08-18 | 2012-02-23 | Boston Scientific Neuromodulation Corporation | Methods, systems, and devices for deep brain stimulation using helical movement of the centroid of stimulation |
US8583237B2 (en) | 2010-09-13 | 2013-11-12 | Cranial Medical Systems, Inc. | Devices and methods for tissue modulation and monitoring |
US8694127B2 (en) | 2010-09-21 | 2014-04-08 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using radially-aligned segmented electrodes for leads of electrical stimulation systems |
EP2654876B1 (en) | 2010-12-23 | 2014-12-10 | Boston Scientific Neuromodulation Corporation | Method and assembly for making a medical lead including removing raised connectors by grinding |
US8700179B2 (en) | 2011-02-02 | 2014-04-15 | Boston Scientific Neuromodulation Corporation | Leads with spiral of helical segmented electrode arrays and methods of making and using the leads |
ES2548833T3 (en) | 2011-02-08 | 2015-10-21 | Boston Scientific Neuromodulation Corporation | Cables with segmented electrodes for electrical stimulation systems |
ES2717196T3 (en) | 2011-02-08 | 2019-06-19 | Boston Scient Neuromodulation Corp | Lead wires with segmented electrodes that have a channel and manufacturing procedures for the lead wires |
US20120203316A1 (en) | 2011-02-08 | 2012-08-09 | Boston Scientific Neuromodulation Corporation | Leads with segmented electrodes for electrical stimulation of planar regions and methods of making and using |
US9138576B2 (en) | 2011-10-28 | 2015-09-22 | Medtronic, Inc. | Lead end having inner support |
US8831742B2 (en) | 2012-01-26 | 2014-09-09 | Boston Scientific Neuromodulation Corporation | Systems and methods for identifying the circumferential positioning of electrodes of leads for electrical stimulation systems |
WO2013148092A1 (en) | 2012-03-30 | 2013-10-03 | Boston Scientific Neuromodulation Corporation | Leads with x-ray fluorescent capsules for electrode identification and methods of manufacture and use |
EP2841149B1 (en) | 2012-04-27 | 2020-07-08 | Medtronic, Inc. | Method and system for fabricating a medical lead using an electrode fixture |
US20130317587A1 (en) | 2012-05-25 | 2013-11-28 | Boston Scientific Neuromodulation Corporation | Methods for stimulating the dorsal root ganglion with a lead having segmented electrodes |
JP5926453B2 (en) | 2012-06-01 | 2016-05-25 | ボストン サイエンティフィック ニューロモデュレイション コーポレイション | Lead having tip electrode for electrical stimulation system and method of making and using the same |
EP2877236B1 (en) | 2012-07-26 | 2023-03-29 | Medtronic, Inc. | Implantable medical leads |
US8897891B2 (en) | 2012-08-03 | 2014-11-25 | Boston Scientific Neuromodulation Corporation | Leads with electrode carrier for segmented electrodes and methods of making and using |
-
2012
- 2012-02-08 US US13/368,733 patent/US20120203316A1/en not_active Abandoned
-
2014
- 2014-10-17 US US14/517,746 patent/US9283375B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7047084B2 (en) * | 2002-11-20 | 2006-05-16 | Advanced Neuromodulation Systems, Inc. | Apparatus for directionally stimulating nerve tissue |
US20070112403A1 (en) * | 2005-11-16 | 2007-05-17 | Moffitt Michael A | Electrode contact configurations for an implantable stimulator |
US20100268298A1 (en) * | 2009-04-16 | 2010-10-21 | Boston Scientific Neuromodulation Corporation | Deep brain stimulation current steering with split electrodes |
Cited By (275)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9283394B2 (en) | 2002-06-20 | 2016-03-15 | Boston Scientific Neuromodulation Corporation | Implantable microstimulators and methods for unidirectional propagation of action potentials |
US10166385B2 (en) | 2006-07-31 | 2019-01-01 | Boston Scientific Neuromodulation Corporation | Lead and methods for brain monitoring and modulation |
US9314614B2 (en) | 2006-07-31 | 2016-04-19 | Boston Scientific Neuromodulation Corporation | Lead and methods for brain monitoring and modulation |
US8849415B2 (en) | 2006-07-31 | 2014-09-30 | Boston Scientific Neuromodulation Corporation | Multi-channel connector for brain stimulation system |
US9630000B2 (en) | 2007-03-19 | 2017-04-25 | Boston Scientific Neuromodulation Corporation | Methods and apparatus for fabricating leads with conductors and related flexible lead configurations |
US10391307B2 (en) | 2007-03-19 | 2019-08-27 | Boston Scientific Neuromodulation Corporation | MRI and RF compatible leads and related methods of operating and fabricating leads |
US9248270B2 (en) | 2007-03-19 | 2016-02-02 | Boston Scientific Neuromodulation Corporation | Methods and apparatus for fabricating leads with conductors and related flexible |
US8897889B2 (en) | 2008-10-09 | 2014-11-25 | Boston Scientific Neuromodulation Corporation | Electrode design for leads of implantable electric stimulation systems and methods of making and using |
US8914121B2 (en) | 2009-04-16 | 2014-12-16 | Boston Scientific Neuromodulation Corporation | Deep brain stimulation current steering with split electrodes |
US9211402B2 (en) | 2009-04-16 | 2015-12-15 | Boston Scientific Neuromodulation Corporation | Deep brain stimulation current steering with split electrodes |
US9393403B2 (en) | 2009-04-16 | 2016-07-19 | Boston Scientific Neuromodulation Corporation | Deep brain stimulation current steering with split electrodes |
US8649873B2 (en) | 2009-04-16 | 2014-02-11 | Boston Scientific Neuromodulation Corporation | Deep brain stimulation current steering with split electrodes |
US8875391B2 (en) | 2009-07-07 | 2014-11-04 | Boston Scientific Neuromodulation Corporation | Methods for making leads with radially-aligned segmented electrodes for electrical stimulation systems |
US20110078900A1 (en) * | 2009-07-07 | 2011-04-07 | Boston Scientific Neuromodulation Corporation | Methods for making leads with radially-aligned segmented electrodes for electrical stimulation systems |
US10720729B2 (en) | 2009-07-07 | 2020-07-21 | Boston Scientific Neuromodulation Corporation | Systems and leads with a radially segmented electrode array and methods of manufacture |
US9270070B2 (en) | 2009-07-07 | 2016-02-23 | Boston Scientific Neuromodulation Corporation | Methods of manufacturing leads with a radially segmented electrode array |
US9913974B2 (en) | 2009-07-07 | 2018-03-13 | Boston Scientific Neuromodulation Corporation | Methods for making leads with radially-aligned segmented electrodes for electrical stimulation systems |
US9168369B2 (en) | 2009-11-30 | 2015-10-27 | Boston Scientific Neuromodulation Corporation | Electrode array having a rail system and methods of manufacturing the same |
US8666509B2 (en) | 2009-11-30 | 2014-03-04 | Boston Scientific Neuromodulation Corporation | Electrode array with electrodes having cutout portions and methods of making the same |
US8874232B2 (en) | 2009-11-30 | 2014-10-28 | Boston Scientific Neuromodulation Corporation | Electrode array having concentric split ring electrodes and methods of making the same |
US8560074B2 (en) | 2009-11-30 | 2013-10-15 | Boston Scientific Neuromodulation Corporation | Electrode array having concentric windowed cylinder electrodes and methods of making the same |
US20110130818A1 (en) * | 2009-11-30 | 2011-06-02 | Boston Scientific Neuromodulation Corporation | Electrode array having concentric split ring electrodes and methods of making the same |
US8788063B2 (en) | 2009-11-30 | 2014-07-22 | Boston Scientific Neuromodulation Corporation | Electrode array having a rail system and methods of manufacturing the same |
US20110130817A1 (en) * | 2009-11-30 | 2011-06-02 | Boston Scientific Neuromodulation Corporation | Electrode array having a rail system and methods of manufacturing the same |
US9248277B2 (en) | 2009-11-30 | 2016-02-02 | Boston Scientific Neuromodulation Corporation | Electrode array having concentric split ring electrodes and methods of making the same |
US8868206B2 (en) | 2010-06-18 | 2014-10-21 | Boston Scientific Neuromodulation Corporation | Electrode array having embedded electrodes and methods of making the same |
US9855417B2 (en) | 2010-06-18 | 2018-01-02 | Boston Scientific Neuromodulation Corporation | Method of making an electrode array having embedded electrodes |
US9162049B2 (en) | 2010-09-13 | 2015-10-20 | Boston Scientific Neuromodulation Corporation | Devices and methods for tissue modulation and monitoring |
US9795779B2 (en) | 2010-09-21 | 2017-10-24 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using radially-aligned segmented electrodes for leads of electrical stimulation systems |
US9295830B2 (en) | 2010-12-23 | 2016-03-29 | Boston Scientific Neuromodulation Corporation | Methods for making leads with segmented electrodes for electrical stimulation systems |
US8862242B2 (en) | 2010-12-23 | 2014-10-14 | Boston Scientific Neuromodulation Corporation | Methods for making leads with segmented electrodes for electrical stimulation systems |
US9248276B2 (en) | 2011-02-02 | 2016-02-02 | Boston Scientific Neuromodulation Corporation | Leads with spiral of helical segmented electrode arrays and methods of making and using the leads |
US9283375B2 (en) | 2011-02-08 | 2016-03-15 | Boston Scientific Neuromodulation Corporation | Leads with segmented electrodes for electrical stimulation of planar regions and methods of making and using |
US9248275B2 (en) | 2011-02-08 | 2016-02-02 | Boston Scientific Neuromodulation Corporation | Methods of making leads with retention features for segmented electrodes |
US10123717B2 (en) * | 2011-11-10 | 2018-11-13 | Neuropace, Inc. | Multimodal brain sensing lead |
US11026617B2 (en) | 2011-11-10 | 2021-06-08 | Neuropace, Inc. | Multimodal brain sensing lead |
US10390721B2 (en) | 2011-11-10 | 2019-08-27 | Neuropace, Inc. | Multimodal brain sensing lead |
US20130123600A1 (en) * | 2011-11-10 | 2013-05-16 | Neuropace, Inc. | Multimodal Brain Sensing Lead |
US11690553B2 (en) | 2011-11-10 | 2023-07-04 | Neuropace, Inc. | Multimodal brain sensing lead |
US8831742B2 (en) | 2012-01-26 | 2014-09-09 | Boston Scientific Neuromodulation Corporation | Systems and methods for identifying the circumferential positioning of electrodes of leads for electrical stimulation systems |
US8744596B2 (en) | 2012-03-30 | 2014-06-03 | Boston Scientific Neuromodulation Corporation | Leads with X-ray fluorescent capsules for electrode identification and methods of manufacture and use |
US8923982B2 (en) | 2012-03-30 | 2014-12-30 | Boston Scientific Neuromodulation Corporation | Leads with X-ray fluorescent capsules for electrode identification and methods of manufacture and use |
US9827413B2 (en) | 2012-04-17 | 2017-11-28 | Boston Scientific Neuromodulation Corporation | Lead construction for deep brain stimulation |
US9878148B2 (en) | 2012-04-17 | 2018-01-30 | Boston Scientific Neuromodulation Corporation | Lead with contact end conductor guide and methods of making and using |
US11020586B2 (en) | 2012-05-25 | 2021-06-01 | Boston Scientific Neuromodulation Corporation | Distally curved electrical stimulation lead and methods of making and using |
US8983625B2 (en) | 2012-05-25 | 2015-03-17 | Boston Scientific Neuromodulation Corporation | Systems and methods for electrically stimulating patient tissue on or around one or more bony structures |
WO2013177307A1 (en) | 2012-05-25 | 2013-11-28 | Boston Scientific Neuromodulation Corporation | Percutaneous implantation of an electrical stimulation lead for stimulating dorsal root ganglion |
WO2013177159A1 (en) | 2012-05-25 | 2013-11-28 | Boston Scientific Neuromodulation Corporation | Systems and methods for electrically stimulating patient tissue on or around one or more bony structures |
WO2013177145A1 (en) | 2012-05-25 | 2013-11-28 | Boston Scientific Neuromodulation Corporation | Methods for stimulating the dorsal root ganglion with a lead having segmented electrodes |
US9199074B2 (en) | 2012-05-25 | 2015-12-01 | Boston Scientific Neuromodulation Corporation | Percutaneous implantation of an electrical stimulation lead for stimulating dorsal root ganglion |
US8849422B2 (en) | 2012-05-25 | 2014-09-30 | Boston Scientific Neuromodulation Corporation | Percutaneous implantation of an electrical stimulation lead for stimulating dorsal root ganglion |
US8768488B2 (en) | 2012-05-25 | 2014-07-01 | Boston Scientific Neuromodulation Corporation | Systems and methods for electrically stimulating patient tissue on or around one or more bony structures |
US9919148B2 (en) | 2012-05-25 | 2018-03-20 | Boston Scientific Neuromodulation Corporation | Distally curved electrical stimulation lead and methods of making and using |
WO2013181519A2 (en) | 2012-06-01 | 2013-12-05 | Boston Scientific Neuromodulation Corporation | Leads with tip electrode for electrical stimulation systems and methods of making and using |
US8996132B2 (en) | 2012-06-01 | 2015-03-31 | Boston Scientific Neuromodulation Corporation | Leads with tip electrode for electrical stimulation systems and methods of making and using |
US8792993B2 (en) | 2012-06-01 | 2014-07-29 | Boston Scientific, Neuromodulation Corporation | Leads with tip electrode for electrical stimulation systems and methods of making and using |
US9427567B2 (en) | 2012-08-03 | 2016-08-30 | Boston Scientific Neuromodulation Corporation | Leads with electrode carrier for segmented electrodes and methods of making and using |
US8897891B2 (en) | 2012-08-03 | 2014-11-25 | Boston Scientific Neuromodulation Corporation | Leads with electrode carrier for segmented electrodes and methods of making and using |
US9227050B2 (en) | 2012-08-03 | 2016-01-05 | Boston Scientific Neuromodulation Corporation | Leads with electrode carrier for segmented electrodes and methods of making and using |
CN107398013A (en) * | 2012-12-24 | 2017-11-28 | 电子运动医疗有限公司 | For arousing the device of continuous contraction of muscle in gastrointestinal organ |
US11311726B2 (en) | 2013-03-15 | 2022-04-26 | Boston Scientific Neuromodulation Corporation | Neuromodulation system and method for transitioning between programming modes |
US9616220B2 (en) | 2013-05-15 | 2017-04-11 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using tip electrodes for leads of electrical stimulation systems |
US9162048B2 (en) | 2013-05-15 | 2015-10-20 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using tip electrodes for leads of electrical stimulation systems |
WO2014193761A1 (en) | 2013-05-31 | 2014-12-04 | Boston Scientific Neuromodulation Corporation | Methods for manufacturing segmented electrode leads using a removable ring and the leads formed thereby |
US9381347B2 (en) | 2013-05-31 | 2016-07-05 | Boston Scientific Neuromodulation Corporation | Segmented electrode leads formed from pre-electrodes with alignment features and methods of making and using the leads |
US9498620B2 (en) | 2013-05-31 | 2016-11-22 | Boston Scientific Neuromodulation Corporation | Leads containing segmented electrodes with non-perpendicular legs and methods of making and using |
US9381348B2 (en) | 2013-05-31 | 2016-07-05 | Boston Scientific Neuromodulation Corporation | Leads with segmented electrodes and methods of making and using the leads |
US9248272B2 (en) | 2013-05-31 | 2016-02-02 | Boston Scientific Neuromodulation Corporation | Segmented electrode leads formed from pre-electrodes with depressions or apertures and methods of making and using |
WO2014193762A2 (en) | 2013-05-31 | 2014-12-04 | Boston Scientific Neuromodulation Corporation | Leads containing segmented electrodes with non-perpendicular legs and methods of making and using |
WO2014193759A1 (en) | 2013-05-31 | 2014-12-04 | Boston Scientific Neuromodulation Corporation | Segmented electrode leads formed from pre-electrodes with alignment features and mehods of making and using the leads |
US9149630B2 (en) | 2013-05-31 | 2015-10-06 | Boston Scientific Neuromodulation Corporation | Segmented electrode leads formed from pre-electrodes with alignment features and methods of making and using the leads |
WO2015006239A1 (en) | 2013-07-12 | 2015-01-15 | Boston Scientific Neuromodulation Corporation | Leads with segmented electrodes and methods of making and using the leads |
US9289596B2 (en) | 2013-07-12 | 2016-03-22 | Boston Scientific Neuromodulation Corporation | Leads with segmented electrodes and methods of making and using the leads |
US9655528B2 (en) | 2013-07-15 | 2017-05-23 | Boston Scientific Neuromodulation Corporation | Systems and methods for detecting cerebrospinal-fluid pulsation using an implantable electrical stimulation device |
US9566747B2 (en) | 2013-07-22 | 2017-02-14 | Boston Scientific Neuromodulation Corporation | Method of making an electrical stimulation lead |
US9302113B2 (en) | 2013-07-29 | 2016-04-05 | Boston Scientific Neuromodulation Corporation | Systems and methods for identifying anode placement based on cerebrospinal fluid thickness |
US9089689B2 (en) | 2013-08-30 | 2015-07-28 | Boston Scientific Neuromodulation Corporation | Methods of making segmented electrode leads using flanged carrier |
WO2015031375A1 (en) | 2013-08-30 | 2015-03-05 | Boston Scientific Neuromodulation Corporation | Methods of making segmented electrode leads using flanged carrier |
WO2015084745A1 (en) | 2013-12-02 | 2015-06-11 | Boston Scientific Neuromodulation Corporation | Electrical stimulation leads with helically arranged electrodes and methods for their manufacture |
US9775988B2 (en) | 2013-12-02 | 2017-10-03 | Boston Scientific Neuromodulation Corporation | Electrical stimulation leads with helically arranged electrodes and methods of making and using |
US9440066B2 (en) | 2014-01-27 | 2016-09-13 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using connector assemblies for implantable medical device systems |
WO2015192058A1 (en) | 2014-06-13 | 2015-12-17 | Boston Scientific Neuromodulation Corporation | Leads with electrode carriers for segmented electrodes and methods of making and using |
US9962541B2 (en) | 2014-06-13 | 2018-05-08 | Boston Scientific Neuromodulation Corporation | Leads with electrode carriers for segmented electrodes and methods of making and using |
US9770598B2 (en) | 2014-08-29 | 2017-09-26 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using improved connector contacts for electrical stimulation systems |
US9814881B2 (en) | 2014-09-22 | 2017-11-14 | Boston Scientific Neuromodulation Corporation | Systems and methods for providing therapy using electrical stimulation to disrupt neuronal activity |
US10004902B2 (en) | 2014-09-22 | 2018-06-26 | Lowe Graham Jones PLLC | Devices and methods using a pathological frequency in electrical stimulation for pain management |
US11691012B2 (en) | 2014-09-22 | 2023-07-04 | Boston Scientific Neuromodulation Corporation | Devices and methods to use power spectrum or signal association for pain management |
US10130816B2 (en) | 2014-09-22 | 2018-11-20 | Boston Scientific Neruomodulation Corporation | Devices and methods to use power spectrum or signal association for pain management |
US10369364B2 (en) | 2014-09-22 | 2019-08-06 | Boston Scientific Neuromodulation Corporation | Devices and methods to use power spectrum or signal association for pain management |
US9925378B2 (en) | 2014-09-22 | 2018-03-27 | Boston Scientific Neuromodulation Corporation | Devices and methods to use power spectrum or signal association for pain management |
US9833622B2 (en) | 2014-09-22 | 2017-12-05 | Boston Scientific Neuromodulation Corporation | Devices and methods using a pathological frequency in electrical stimulation for pain management |
US9925377B2 (en) | 2014-09-22 | 2018-03-27 | Boston Scientific Neuromodulation Corporation | Systems and methods for providing therapy using electrical stimulation to disrupt neuronal activity |
US11110276B2 (en) | 2014-09-22 | 2021-09-07 | Boston Scientific Neuromodulation Corporation | Devices and methods to use power spectrum or signal association for pain management |
WO2016049047A2 (en) | 2014-09-22 | 2016-03-31 | Boston Scientific Neuromodulation Corporation | Systems and methods for providing therapy using electrical stimulation to disrupt neuronal activity |
US9901737B2 (en) | 2014-09-22 | 2018-02-27 | Boston Scientific Neuromodulation Corporation | Systems and methods for providing therapy to a patient using intermittent electrical stimulation |
US9901732B2 (en) | 2014-10-24 | 2018-02-27 | Medtronic, Inc. | Medical electrical lead |
WO2016065263A1 (en) * | 2014-10-24 | 2016-04-28 | Medtronic, Inc. | Medical electrical lead |
US10016591B2 (en) | 2014-10-24 | 2018-07-10 | Medtronic, Inc. | Medical electrical lead |
CN107073271A (en) * | 2014-10-24 | 2017-08-18 | 美敦力公司 | Medical electrical lead |
US10532206B2 (en) | 2014-10-24 | 2020-01-14 | Medtronic, Inc. | Coronary sinus medical electrical lead |
WO2016065266A1 (en) * | 2014-10-24 | 2016-04-28 | Medtronic, Inc. | Medical electrical lead |
US10039494B2 (en) | 2014-10-28 | 2018-08-07 | Biosense Webster (Israel) Ltd. | Basket catheter with microelectrode array distal tip |
US10939871B2 (en) | 2014-10-28 | 2021-03-09 | Biosense Webster (Israel) Ltd. | Basket catheter with microelectrode array distal tip |
US9314208B1 (en) | 2014-10-28 | 2016-04-19 | Biosense Webster (Israel) Ltd. | Basket catheter with microelectrode array distal tip |
US10470714B2 (en) | 2014-10-28 | 2019-11-12 | Biosense Webster (Israel) Ltd. | Basket catheter with microelectrode array distal tip |
US9693733B2 (en) | 2014-10-28 | 2017-07-04 | Biosense Webster (Israel) Ltd. | Basket catheter with microelectrode array distal tip |
WO2016073316A1 (en) | 2014-11-03 | 2016-05-12 | Boston Scientific Neuromodulation Corporation | Electrical stimulation system with anchoring stylet and methods of making and using |
US9561362B2 (en) | 2014-11-10 | 2017-02-07 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using improved contact arrays for electrical stimulation systems |
US9764149B2 (en) | 2014-11-10 | 2017-09-19 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using improved connector contacts for electrical stimulation systems |
US9604068B2 (en) | 2014-11-10 | 2017-03-28 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using improved connector contacts for electrical stimulation systems |
US10286205B2 (en) | 2015-02-06 | 2019-05-14 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using improved contact arrays for electrical stimulation systems |
US9833611B2 (en) | 2015-04-10 | 2017-12-05 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using improved contact arrays for electrical stimulation systems |
WO2016191436A1 (en) | 2015-05-26 | 2016-12-01 | Boston Scientific Neuromodulation Corporation | Systems and methods for analyzing electrical stimulation and selecting or manipulating volumes of activation |
US11160981B2 (en) | 2015-06-29 | 2021-11-02 | Boston Scientific Neuromodulation Corporation | Systems and methods for selecting stimulation parameters based on stimulation target region, effects, or side effects |
US10441800B2 (en) | 2015-06-29 | 2019-10-15 | Boston Scientific Neuromodulation Corporation | Systems and methods for selecting stimulation parameters by targeting and steering |
US11110280B2 (en) | 2015-06-29 | 2021-09-07 | Boston Scientific Neuromodulation Corporation | Systems and methods for selecting stimulation parameters by targeting and steering |
WO2017011477A1 (en) | 2015-07-16 | 2017-01-19 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using connector contact arrays for electrical stimulation systems |
US9839787B2 (en) | 2015-07-16 | 2017-12-12 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using connector contact arrays for electrical stimulation systems |
US9656093B2 (en) | 2015-07-16 | 2017-05-23 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using connector contact arrays for electrical stimulation systems |
US10232169B2 (en) | 2015-07-23 | 2019-03-19 | Boston Scientific Neuromodulation Corporation | Burr hole plugs for electrical stimulation systems and methods of making and using |
US10067659B2 (en) | 2015-08-24 | 2018-09-04 | Boston Scientific Neuromodulation Corporation | Systems and methods for determining orientation of an implanted lead |
WO2017035158A1 (en) | 2015-08-24 | 2017-03-02 | Boston Scientific Neuromodulation Corporation | Systems and methods for determining orientation of an electrical stimulation lead |
US10265531B2 (en) | 2015-09-01 | 2019-04-23 | Boston Scientific Neuromodulation Corporation | Detection of lead orientation |
US9956394B2 (en) | 2015-09-10 | 2018-05-01 | Boston Scientific Neuromodulation Corporation | Connectors for electrical stimulation systems and methods of making and using |
US10413737B2 (en) | 2015-09-25 | 2019-09-17 | Boston Scientific Neuromodulation Corporation | Systems and methods for providing therapy using electrical stimulation to disrupt neuronal activity |
US10071249B2 (en) | 2015-10-09 | 2018-09-11 | Boston Scientific Neuromodulation Corporation | System and methods for clinical effects mapping for directional stimulation leads |
US9986989B2 (en) | 2016-01-08 | 2018-06-05 | Boston Scientific Neuromodulation Corporation | Surgical retractor for implanting leads and methods of making and using |
US10342983B2 (en) | 2016-01-14 | 2019-07-09 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using connector contact arrays for electrical stimulation systems |
WO2017136346A1 (en) | 2016-02-05 | 2017-08-10 | Boston Scientfic Neuromodulation Corporation | Implantable optical stimulation lead |
US11511127B2 (en) | 2016-02-05 | 2022-11-29 | Boston Scientific Neuromodulation Corporation | Implantable optical stimulation lead and methods of making and using |
US10335607B2 (en) | 2016-02-05 | 2019-07-02 | Boston Scientific Neuromodulation Corporation | Implantable optical stimulation lead and methods of making and using |
US10485969B2 (en) | 2016-02-19 | 2019-11-26 | Boston Scientific Neuromodulation Corporation | Electrical stimulation cuff devices and systems |
WO2017143254A1 (en) | 2016-02-19 | 2017-08-24 | Boston Scientific Neuromodulation Corporation | Electrical stimulation cuff devices and systems |
WO2017151438A1 (en) | 2016-02-29 | 2017-09-08 | Boston Scientific Neuromodulation Corporation | Lead anchor for an electrical stimulation system |
US10071242B2 (en) | 2016-02-29 | 2018-09-11 | Boston Scientific Neuromodulation Corporation | Lead anchor for an electrical stimulation system |
US10124161B2 (en) | 2016-03-31 | 2018-11-13 | Boston Scientific Neuromodulation Corporation | Neurostimulation lead with conductive elements and methods for making the same |
US10716942B2 (en) | 2016-04-25 | 2020-07-21 | Boston Scientific Neuromodulation Corporation | System and methods for directional steering of electrical stimulation |
WO2017201058A1 (en) | 2016-05-17 | 2017-11-23 | Boston Scientific Neuromodulation Corporation | Systems and methods for anchoring a lead for neurostimulation of a target anatomy |
US10369354B2 (en) | 2016-05-17 | 2019-08-06 | Boston Scientific Neuromodulation Corporation | Systems and method for anchoring a lead for neurostimulation of a target anatomy |
US10493269B2 (en) | 2016-06-02 | 2019-12-03 | Boston Scientific Neuromodulation Corporation | Leads for electrostimulation of peripheral nerves and other targets |
US10201713B2 (en) | 2016-06-20 | 2019-02-12 | Boston Scientific Neuromodulation Corporation | Threaded connector assembly and methods of making and using the same |
WO2017223505A2 (en) | 2016-06-24 | 2017-12-28 | Boston Scientific Neuromodulation Corporation | Systems and methods for visual analytics of clinical effects |
US10776456B2 (en) | 2016-06-24 | 2020-09-15 | Boston Scientific Neuromodulation Corporation | Systems and methods for visual analytics of clinical effects |
US10307602B2 (en) | 2016-07-08 | 2019-06-04 | Boston Scientific Neuromodulation Corporation | Threaded connector assembly and methods of making and using the same |
WO2018022455A1 (en) | 2016-07-29 | 2018-02-01 | Boston Scientific Neuromodulation Corporation | Connector assembly with contact rings comprising biased ball-spring contacts |
US10709888B2 (en) | 2016-07-29 | 2020-07-14 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using an electrical stimulation system for peripheral nerve stimulation |
WO2018022460A1 (en) | 2016-07-29 | 2018-02-01 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using an electrical stimulation system for peripheral nerve stimulation |
US11590350B2 (en) | 2016-08-22 | 2023-02-28 | Boston Scientific Neuromodulation Corporation | Systems and methods for delivering spinal cord stimulation therapy |
US10780274B2 (en) | 2016-08-22 | 2020-09-22 | Boston Scientific Neuromodulation Corporation | Systems and methods for delivering spinal cord stimulation therapy |
US10350404B2 (en) | 2016-09-02 | 2019-07-16 | Boston Scientific Neuromodulation Corporation | Systems and methods for visualizing and directing stimulation of neural elements |
WO2018044881A1 (en) | 2016-09-02 | 2018-03-08 | Boston Scientific Neuromodulation Corporation | Systems and methods for visualizing and directing stimulation of neural elements |
US10780282B2 (en) | 2016-09-20 | 2020-09-22 | Boston Scientific Neuromodulation Corporation | Systems and methods for steering electrical stimulation of patient tissue and determining stimulation parameters |
US10543374B2 (en) | 2016-09-30 | 2020-01-28 | Boston Scientific Neuromodulation Corporation | Connector assemblies with bending limiters for electrical stimulation systems and methods of making and using same |
US10603498B2 (en) | 2016-10-14 | 2020-03-31 | Boston Scientific Neuromodulation Corporation | Systems and methods for closed-loop determination of stimulation parameter settings for an electrical simulation system |
US10525257B2 (en) | 2016-10-14 | 2020-01-07 | Boston Scientific Neuromodulation Corporation | Orientation marker for implantable leads and leads, systems, and methods utilizing the orientation marker |
WO2018071842A1 (en) | 2016-10-14 | 2018-04-19 | Boston Scientific Neuromodulation Corporation | Systems and methods for determining orientation of an implanted lead |
WO2018071420A1 (en) | 2016-10-14 | 2018-04-19 | Boston Scientific Neuromodulation Corporation | Orientation marker for implantable leads, and leads and systems utilizing the orientation marker |
US11752348B2 (en) | 2016-10-14 | 2023-09-12 | Boston Scientific Neuromodulation Corporation | Systems and methods for closed-loop determination of stimulation parameter settings for an electrical simulation system |
WO2018071865A1 (en) | 2016-10-14 | 2018-04-19 | Boston Scientific Neuromodulation Corporation | Systems and methods for closed-loop determination of stimulation parameter settings for an electrical simulation system |
US10625072B2 (en) | 2016-10-21 | 2020-04-21 | Boston Scientific Neuromodulation Corporation | Electrical stimulation methods with optical observation and devices therefor |
US10716935B2 (en) | 2016-11-04 | 2020-07-21 | Boston Scientific Neuromodulation Corporation | Electrical stimulation leads, systems and methods for stimulation of dorsal root ganglia |
US10603485B2 (en) | 2016-11-28 | 2020-03-31 | Boston Scientific Neuromodulation Corporation | Features in increased surface area on neuromodulation leads |
WO2018102773A1 (en) | 2016-12-02 | 2018-06-07 | Boston Scientific Neuromodulation Corporation | Methods and systems for selecting stimulation parameters for electrical stimulation devices |
US10905883B2 (en) | 2016-12-02 | 2021-02-02 | Boston Scientific Neuromodulation Corporation | Methods and systems for selecting stimulation parameters for electrical stimulation devices |
US10792501B2 (en) | 2017-01-03 | 2020-10-06 | Boston Scientific Neuromodulation Corporation | Systems and methods for selecting MRI-compatible stimulation parameters |
WO2018128949A1 (en) | 2017-01-03 | 2018-07-12 | Boston Scientific Neuromodulation Corporation | Systems and methods for selecting mri-compatible stimulation parameters |
US10576269B2 (en) | 2017-01-03 | 2020-03-03 | Boston Scientific Neuromodulation Corporation | Force-decoupled and strain relieving lead and methods of making and using |
WO2018132367A1 (en) | 2017-01-10 | 2018-07-19 | Boston Scientific Neuromodulation Corporation | Patterned stimulation for deep brain stimulation |
WO2018132334A1 (en) | 2017-01-10 | 2018-07-19 | Boston Scientific Neuromodulation Corporation | Systems and methods for creating stimulation programs based on user-defined areas or volumes |
US10589104B2 (en) | 2017-01-10 | 2020-03-17 | Boston Scientific Neuromodulation Corporation | Systems and methods for creating stimulation programs based on user-defined areas or volumes |
US10905871B2 (en) | 2017-01-27 | 2021-02-02 | Boston Scientific Neuromodulation Corporation | Lead assemblies with arrangements to confirm alignment between terminals and contacts |
WO2018160495A1 (en) | 2017-02-28 | 2018-09-07 | Boston Scientific Neuromodulation Corporation | Toolless connector for latching stimulation leads and methods of making and using |
US10814136B2 (en) | 2017-02-28 | 2020-10-27 | Boston Scientific Neuromodulation Corporation | Toolless connector for latching stimulation leads and methods of making and using |
US10709886B2 (en) | 2017-02-28 | 2020-07-14 | Boston Scientific Neuromodulation Corporation | Electrical stimulation leads and systems with elongate anchoring elements and methods of making and using |
US10625082B2 (en) | 2017-03-15 | 2020-04-21 | Boston Scientific Neuromodulation Corporation | Visualization of deep brain stimulation efficacy |
US10835739B2 (en) | 2017-03-24 | 2020-11-17 | Boston Scientific Neuromodulation Corporation | Electrical stimulation leads and systems with elongate anchoring elements and methods of making and using |
WO2018187090A1 (en) | 2017-04-03 | 2018-10-11 | Boston Scientific Neuromodulation Corporation | Systems and methods for estimating a volume of activation using a compressed database of threshold values |
US11357986B2 (en) | 2017-04-03 | 2022-06-14 | Boston Scientific Neuromodulation Corporation | Systems and methods for estimating a volume of activation using a compressed database of threshold values |
US10603499B2 (en) | 2017-04-07 | 2020-03-31 | Boston Scientific Neuromodulation Corporation | Tapered implantable lead and connector interface and methods of making and using |
US10631937B2 (en) | 2017-04-14 | 2020-04-28 | Boston Scientific Neuromodulation Corporation | Systems and methods for determining orientation of an implanted electrical stimulation lead |
US10857351B2 (en) | 2017-04-28 | 2020-12-08 | Boston Scientific Neuromodulation Corporation | Lead anchors for electrical stimulation leads and systems and methods of making and using |
WO2018217497A1 (en) | 2017-05-22 | 2018-11-29 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using a lead introducer for an electrical stimulation system |
WO2019005684A1 (en) | 2017-06-26 | 2019-01-03 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using implantable optical stimulation leads and assemblies |
WO2019005689A1 (en) | 2017-06-26 | 2019-01-03 | Boston Scientific Neuromodulation Corporation | Systems and methods for visualizing and controlling optogenetic stimulation using optical stimulation systems |
US10814140B2 (en) | 2017-06-26 | 2020-10-27 | Boston Scientific Neuromodulation Corporation | Systems and methods for visualizing and controlling optogenetic stimulation using optical stimulation systems |
WO2019014217A1 (en) | 2017-07-14 | 2019-01-17 | Boston Scientific Neuromodulation Corporation | Systems and methods for planning and programming electrical stimulation |
WO2019014224A1 (en) | 2017-07-14 | 2019-01-17 | Boston Scientific Neuromodulation Corporation | Systems and methods for estimating clinical effects of electrical stimulation |
US10716505B2 (en) | 2017-07-14 | 2020-07-21 | Boston Scientific Neuromodulation Corporation | Systems and methods for estimating clinical effects of electrical stimulation |
WO2019023067A1 (en) | 2017-07-25 | 2019-01-31 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using an enhanced connector of an electrical stimulation system |
US10918873B2 (en) | 2017-07-25 | 2021-02-16 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using an enhanced connector of an electrical stimulation system |
US10960214B2 (en) | 2017-08-15 | 2021-03-30 | Boston Scientific Neuromodulation Corporation | Systems and methods for controlling electrical stimulation using multiple stimulation fields |
WO2019036180A1 (en) | 2017-08-15 | 2019-02-21 | Boston Scientific Neuromodulation Corporation | Systems and methods for controlling electrical stimulation using multiple stimulation fields |
US11219759B2 (en) | 2017-08-29 | 2022-01-11 | Boston Scientific Neuromodulation Corporation | Systems and methods for introducing an electrical stimulation lead into a patient |
US11045656B2 (en) | 2017-09-15 | 2021-06-29 | Boston Scientific Neuromodulation Corporation | Biased lead connector for operating room cable assembly and methods of making and using |
US11951317B2 (en) | 2017-09-15 | 2024-04-09 | Boston Scientific Neuromodulation Corporation | Biased lead connector for operating room cable assembly and methods of making and using |
US10639485B2 (en) | 2017-09-15 | 2020-05-05 | Boston Scientific Neuromodulation Corporation | Actuatable lead connector for an operating room cable assembly and methods of making and using |
WO2019055837A1 (en) | 2017-09-15 | 2019-03-21 | Boston Scientific Neuromodulation Corporation | Actuatable lead connector for an operating room cable assembly and methods of making and using |
US11139603B2 (en) | 2017-10-03 | 2021-10-05 | Boston Scientific Neuromodulation Corporation | Connectors with spring contacts for electrical stimulation systems and methods of making and using same |
US11103716B2 (en) | 2017-11-13 | 2021-08-31 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using a low-profile control module for an electrical stimulation system |
WO2019094786A1 (en) | 2017-11-13 | 2019-05-16 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using a low-profile control module for an electrical stimulation system |
WO2019099887A1 (en) | 2017-11-17 | 2019-05-23 | Boston Scientific Neuromodulation Corporation | Systems and methods for generating intermittent stimulation using electrical stimulation systems |
US11020592B2 (en) | 2017-11-17 | 2021-06-01 | Boston Scientific Neuromodulation Corporation | Systems and methods for generating intermittent stimulation using electrical stimulation systems |
US10967192B2 (en) | 2017-12-29 | 2021-04-06 | Boston Scientific Neuromodulation Corporation | Systems and methods for charging a medical device implanted into a patient |
US11135438B2 (en) | 2018-01-11 | 2021-10-05 | Boston Scientific Neuromodulation Corporation | Methods and systems for stimulation for glial modulation |
WO2019139883A1 (en) | 2018-01-11 | 2019-07-18 | Boston Scientific Neuromodulation Corporation | Methods and systems for stimulation for glial modulation |
US11103712B2 (en) | 2018-01-16 | 2021-08-31 | Boston Scientific Neuromodulation Corporation | Connector assemblies with novel spacers for electrical stimulation systems and methods of making and using same |
US11497914B2 (en) | 2018-01-16 | 2022-11-15 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using an electrical stimulation system with a case-neutral battery |
WO2019143574A1 (en) | 2018-01-16 | 2019-07-25 | Boston Scientific Neuromodulation Corporation | An electrical stimulation system with a case-neutral battery and a control module for such a system |
US11357544B2 (en) | 2018-01-25 | 2022-06-14 | Boston Scientific Neuromodulation Corporation | Systems and methods for introducing a stimulation lead into a patient |
US11058870B2 (en) | 2018-03-09 | 2021-07-13 | Boston Scientific Neuromodulation Corporation | Burr hole plugs for electrical stimulation systems and methods of making and using |
WO2019173281A1 (en) | 2018-03-09 | 2019-09-12 | Boston Scientific Neuromodulation Corporation | Burr hole plugs for electrical stimulation systems |
WO2019178145A1 (en) | 2018-03-16 | 2019-09-19 | Boston Scientific Neuromodulation Corporation | Kits and methods for securing a burr hole plugs for stimulation systems |
US11013913B2 (en) | 2018-03-16 | 2021-05-25 | Boston Scientific Neuromodulation Corporation | Kits and methods for securing a burr hole plugs for stimulation systems |
WO2019183068A1 (en) | 2018-03-23 | 2019-09-26 | Boston Scientific Neuromodulation Corporation | An optical stimulation system with on-demand monitoring and methods of making and using |
US11565131B2 (en) | 2018-03-23 | 2023-01-31 | Boston Scientific Neuromodulation Corporation | Optical stimulation systems with calibration and methods of making and using |
US11771918B2 (en) | 2018-03-23 | 2023-10-03 | Boston Scientific Neuromodulation Corporation | Optical stimulation system with on-demand monitoring and methods of making and using |
WO2019183078A1 (en) | 2018-03-23 | 2019-09-26 | Boston Scientific Neuromodulation Corporation | Optical stimulation systems using therapy cycling and methods of using |
WO2019183075A1 (en) | 2018-03-23 | 2019-09-26 | Boston Scientific Neuromodulation Corporation | An optical stimulation system with automated monitoring and methods of making and using |
US11524174B2 (en) | 2018-03-23 | 2022-12-13 | Boston Scientific Neuromodulation Corporation | Optical stimulation system with on-demand monitoring and methods of making and using |
WO2019183082A1 (en) | 2018-03-23 | 2019-09-26 | Boston Scientific Neuromodulation Corporation | Implantable prostheses for reducing visibility of bulging from implanted medical devices |
WO2019183054A1 (en) | 2018-03-23 | 2019-09-26 | Boston Scientific Neuromodulation Corporation | Optical stimulation systems with calibration and methods of making and using |
WO2019210214A1 (en) | 2018-04-27 | 2019-10-31 | Boston Scientific Neuromodulation Corporation | Systems for visualizing and programming electrical stimulation |
US11583684B2 (en) | 2018-04-27 | 2023-02-21 | Boston Scientific Neuromodulation Corporation | Systems and methods for visualizing and programming electrical stimulation |
WO2019210202A1 (en) | 2018-04-27 | 2019-10-31 | Boston Scientific Neuromodulation Corporation | Multi-mode electrical stimulation systems and methods of making and using |
US11944823B2 (en) | 2018-04-27 | 2024-04-02 | Boston Scientific Neuromodulation Corporation | Multi-mode electrical stimulation systems and methods of making and using |
US11285329B2 (en) | 2018-04-27 | 2022-03-29 | Boston Scientific Neuromodulation Corporation | Systems and methods for visualizing and programming electrical stimulation |
US11298553B2 (en) | 2018-04-27 | 2022-04-12 | Boston Scientific Neuromodulation Corporation | Multi-mode electrical stimulation systems and methods of making and using |
US11172959B2 (en) | 2018-05-02 | 2021-11-16 | Boston Scientific Neuromodulation Corporation | Long, flexible sheath and lead blank and systems and methods of making and using |
US11052259B2 (en) | 2018-05-11 | 2021-07-06 | Boston Scientific Neuromodulation Corporation | Connector assembly for an electrical stimulation system and methods of making and using |
WO2019217415A1 (en) | 2018-05-11 | 2019-11-14 | Boston Scientific Neuromodulation Corporation | Connector assembly for an electrical stimulation system |
WO2020014083A1 (en) | 2018-07-09 | 2020-01-16 | Boston Scientific Neuromodulation Corporation | Directional electrical stimulation leads and systems for spinal cord stimulation |
US11224743B2 (en) | 2018-09-21 | 2022-01-18 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using modular leads for electrical stimulation systems |
US11167128B2 (en) | 2018-11-16 | 2021-11-09 | Boston Scientific Neuromodulation Corporation | Directional electrical stimulation leads, systems and methods for spinal cord stimulation |
US11426595B2 (en) | 2018-11-16 | 2022-08-30 | Boston Scientific Neuromodulation Corporation | Optical stimulation system with on-demand monitoring and methods of making and using |
US12011604B2 (en) | 2018-11-16 | 2024-06-18 | Boston Scientific Neuromodulation Corporation | Optical stimulation system with on-demand monitoring and methods of making and using |
WO2020102039A1 (en) | 2018-11-16 | 2020-05-22 | Boston Scientific Neuromodulation Corporation | An optical stimulation system with on-demand monitoring and methods of making |
WO2020172071A2 (en) | 2019-02-19 | 2020-08-27 | Boston Scientific Neuromodulation Corporation | Lead introducers and systems and methods including the lead introducers |
US11529510B2 (en) | 2019-02-19 | 2022-12-20 | Boston Scientific Neuromodulation Corporation | Lead introducers and systems and methods including the lead introducers |
WO2020205843A1 (en) | 2019-04-01 | 2020-10-08 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using a low-profile control module for an electrical stimulation system |
US11357992B2 (en) | 2019-05-03 | 2022-06-14 | Boston Scientific Neuromodulation Corporation | Connector assembly for an electrical stimulation system and methods of making and using |
US11612755B2 (en) | 2019-05-03 | 2023-03-28 | Boston Scientific Neuromodulation Corporation | Connector assembly for an electrical stimulation system and methods of making and using |
US11504526B2 (en) | 2019-05-30 | 2022-11-22 | Boston Scientific Neuromodulation Corporation | Methods and systems for discrete measurement of electrical characteristics |
WO2020243096A1 (en) | 2019-05-30 | 2020-12-03 | Boston Scientific Neuromodulation Corporation | Methods and systems for discrete measurement of electrical characteristics |
US11938315B2 (en) | 2019-05-30 | 2024-03-26 | Boston Scientific Neuromodulation Corporation | Methods and systems for discrete measurement of electrical characteristics |
US11623095B2 (en) | 2019-06-20 | 2023-04-11 | Boston Scientific Neuromodulation Corporation | Methods and systems for interleaving waveforms for electrical stimulation and measurement |
WO2020257705A1 (en) | 2019-06-20 | 2020-12-24 | Boston Scientific Neuromodulation Corporation | Methods and systems for interleaving waveforms for electrical stimulation and measurement |
WO2021021659A1 (en) | 2019-07-26 | 2021-02-04 | Boston Scientific Neuromodulation Corporation | Methods and systems for storage, retrieval, and visualization of signals and signal features |
US12053632B2 (en) | 2019-07-26 | 2024-08-06 | Boston Scientific Neuromodulation Corporation | Methods and systems for making electrical stimulation adjustments based on patient-specific factors |
WO2021021662A1 (en) | 2019-07-26 | 2021-02-04 | Boston Scientific Neuromodulation Corporation | Methods and systems for making electrical stimulation adjustments based on patient-specific factors |
WO2021167946A1 (en) | 2020-02-19 | 2021-08-26 | Boston Scientific Neuromodulation Corporation | Methods and systems for treatment of insomnia using deep brain stimulation |
US11806547B2 (en) | 2020-09-04 | 2023-11-07 | Boston Scientific Neuromodulation Corporation | Stimulation systems with a lens arrangement for light coupling and methods of making and using |
WO2022051295A1 (en) | 2020-09-04 | 2022-03-10 | Boston Scientific Neuromodulation Corporation | Stimulation systems with a lens arrangement for light coupling and methods of making and using |
WO2022098554A1 (en) | 2020-11-04 | 2022-05-12 | Boston Scientific Neuromodulation Corporation | Methods and systems for managing access to implantable medical devices |
US12002462B2 (en) | 2020-11-11 | 2024-06-04 | Boston Scientific Neuromodulation Corporation | Voice command handler for programming stimulation systems and methods of using |
WO2022103590A1 (en) | 2020-11-11 | 2022-05-19 | Boston Scientific Neuromodulation Corporation | Voice command handler for programming stimulation systems and methods of using |
WO2022159375A1 (en) | 2021-01-19 | 2022-07-28 | Boston Scientific Neuromodulation Corporation | Electrical stimulation cuff devices and systems with directional electrode configurations |
WO2022182892A1 (en) | 2021-02-25 | 2022-09-01 | Boston Scientific Neuromodulation Corporation | Methods and systems for deep brain stimulation of the nucleus basalis of meynert |
WO2022216844A1 (en) | 2021-04-08 | 2022-10-13 | Boston Scientific Neuromodulation Corporation | Photobiomodulation system and delivery device |
WO2022232036A1 (en) | 2021-04-27 | 2022-11-03 | Boston Scientific Neuromodulation Corporation | Systems and methods for automated programming of electrical stimulation |
WO2022245931A1 (en) | 2021-05-21 | 2022-11-24 | Boston Scientific Neuromodulation Corporation | Electrical stimulation cuff devices and systems with helical arrangement of electrodes |
WO2022261004A1 (en) | 2021-06-07 | 2022-12-15 | Boston Scientific Neuromodulation Corporation | Methods and systems for charge balancing of electrical stimulation |
WO2022261001A1 (en) | 2021-06-07 | 2022-12-15 | Boston Scientific Neuromodulation Corporation | Stimulation systems with user-specified routines and methods of making and using |
WO2022265977A1 (en) | 2021-06-15 | 2022-12-22 | Boston Scientific Neuromodulation Corporation | Methods and systems for estimating neural activation by stimulation using a stimulation system |
WO2023107457A2 (en) | 2021-12-09 | 2023-06-15 | Boston Scientific Neuromodulation Corparation | Methods and systems for monitoring or assessing movement disorders or other physiological parameters using a stimulation system |
WO2023107449A2 (en) | 2021-12-10 | 2023-06-15 | Boston Scientific Neuromodulation Corporation | Systems and methods for generating and using response maps for electrical stimulation |
WO2023107444A1 (en) | 2021-12-10 | 2023-06-15 | Boston Scientific Neuromodulation Corporation | Methods and systems for determining and using an intensity index for electrical stimulation |
WO2023154346A1 (en) | 2022-02-10 | 2023-08-17 | Boston Scientific Neuromodulation Corporation | Automatic therapy adjustment based on sensors |
WO2023163882A1 (en) | 2022-02-24 | 2023-08-31 | Boston Scientific Neuromodulation Corporation | Systems and methods for using cost parameters for programming electrical stimulation |
WO2023167872A1 (en) | 2022-03-02 | 2023-09-07 | Boston Scientific Neuromodulation Corporation | Systems and methods for monitoring stimulation drift in an electrical stimulation system |
WO2024044050A1 (en) | 2022-08-22 | 2024-02-29 | Boston Scientific Neuromodulation Corporation | Implantable photobiomodulation systems employing thermal monitoring or control and methods of making and using |
WO2024044048A1 (en) | 2022-08-22 | 2024-02-29 | Boston Scientific Neuromodulation Corporation | Photobiomodulation systems including an electrode disposed on or over a light emitter and methods of making and using |
EP4368242A1 (en) | 2022-11-14 | 2024-05-15 | Boston Scientific Neuromodulation Corporation | Systems and methods for generating and using stimulation programs with temporal variation |
WO2024129609A1 (en) | 2022-12-14 | 2024-06-20 | Boston Scientific Neuromodulation Corporation | Systems and methods for monitoring and revising electrical stimulation |
WO2024141768A2 (en) | 2022-12-29 | 2024-07-04 | Benabid Alim Louis | Optical stimulation systems and methods for implanting and using |
EP4398258A2 (en) | 2023-01-04 | 2024-07-10 | Boston Scientific Neuromodulation Corporation | Systems and methods incorporating a light therapy user interface for optical modulation |
Also Published As
Publication number | Publication date |
---|---|
US9283375B2 (en) | 2016-03-15 |
US20150038979A1 (en) | 2015-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9283375B2 (en) | Leads with segmented electrodes for electrical stimulation of planar regions and methods of making and using | |
US9427567B2 (en) | Leads with electrode carrier for segmented electrodes and methods of making and using | |
US9566747B2 (en) | Method of making an electrical stimulation lead | |
US9248272B2 (en) | Segmented electrode leads formed from pre-electrodes with depressions or apertures and methods of making and using | |
AU2014274416B2 (en) | Leads containing segmented electrodes with non-perpendicular legs and methods of making and using | |
US9168369B2 (en) | Electrode array having a rail system and methods of manufacturing the same | |
US9295830B2 (en) | Methods for making leads with segmented electrodes for electrical stimulation systems | |
EP3003468B1 (en) | Methods for manufacturing segmented electrode leads using a removable ring and the leads formed thereby | |
US8792993B2 (en) | Leads with tip electrode for electrical stimulation systems and methods of making and using | |
AU2011341668B2 (en) | Methods for making leads with radially-aligned segmented electrodes for electrical stimulation systems | |
US8295944B2 (en) | Electrode array with electrodes having cutout portions and methods of making the same | |
US8649879B2 (en) | Leads with retention features for segmented electrodes and methods of making and using the leads | |
WO2016073316A1 (en) | Electrical stimulation system with anchoring stylet and methods of making and using |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: BOSTON SCIENTIFIC NEUROMODULATION CORPORATION, CAL Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MOFFITT, MICHAEL ADAM;PIANCA, ANNE MARGARET;SIGNING DATES FROM 20120206 TO 20120207;REEL/FRAME:027671/0899 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |